Difference between revisions of "LncRNAWiki:Featured"

From LncRNAWiki
Jump to: navigation, search
 
(38 intermediate revisions by one other user not shown)
Line 1: Line 1:
−
<div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;">
 
−
Jump to section in alphabetical order :  [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']]
 
−
</div>
 
−
 
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
{|class="wikitable sortable" style="width:90%;text-align:center"
 
|-
 
|-
−
!width="50"|Name
+
!width="50"|LncBook ID
−
!width="50"|Transcript ID
+
!width="50"|Symbol
−
!width="50"|Alias
+
!width="50"|Synonyms
−
!width="50"|Description
+
!width="50"|Functional Mechanism
 +
!width="50"|Biological Process
 
!width="50"|Disease
 
!width="50"|Disease
 +
!width="50"|Mesh Ontology
 
|-
 
|-
−
|''21A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289501 HSALNT0289501]
−
|[[NONHSAT128494]]
+
|[[HPVC1]]
−
|ncRNA 21A
+
|PE5L,HPV18E5L
−
|N/A
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''7SK''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289605 HSALNT0289605]
−
|[[NONHSAT113149]]
+
|[[NONHSAT104559]]
−
|"7-3 RNA, K-RNA, 7SK-RNA, 7SK snRNA, RN7SK, ENSG00000202198"
+
|lnc-C9orf53-2:1
−
|"RNA, 7SK small nuclear"
+
|NA
−
|colon adenocarcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''7SL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0199632 HSALNT0199632]
−
|[[lnc-LRR1-1:1]]
+
|[[N4BP2L2-IT2]]
−
|"7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486"
+
|CG030
−
|"RNA, 7SL, cytoplasmic 1"
+
|NA
−
|AIDS
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ABALON''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171094 HSALNT0171094]
−
|[[ABALON]]
+
|[[LINC01150]]
−
|INXS
+
|2G7,TCONS_00019134
−
|apoptotic BCL2L1-antisense long non-coding RNA
+
|NA
−
|renal cell carcinoma
+
|pathogenic process
 +
|Wilms' tumor
 +
|Neoplasms
 
|-
 
|-
−
|''AIRN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289115 HSALNT0289115]
−
|[[ENST00000609176.1]]
+
|[[LINC01587]]
−
|"AIR, IGF2RAS"
+
|C4orf6,aC1
−
|Antisense of IGF2R non-protein coding RNA
+
|NA
−
|Wilms’tumors
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''APOA1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290105 HSALNT0290105]
−
|[[ENST00000444200.1]]
+
|[[NONHSAT115106]]
−
|APOA1 antisense RNA
+
|NONHSAT115106
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''APTR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289234 HSALNT0289234]
−
|[[NONHSAT121673]]
+
|[[RNF217-AS1]]
−
|Alu-mediated CDKN1A/p21
+
|STL
−
|N/A
+
|NA
−
|liver cirrhosis
+
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''BANCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0280481 HSALNT0280481]
−
|[[BANCR]]
+
|[[INE2]]
−
|LINC00586
+
|NCRNA00011
−
|BRAF-activated non-protein coding RNA
+
|NA
−
|gastric cancer, Non-small cell lung cancer(NSCLC), Osteosarcoma, Hepatocellular carcinoma, Malignant melanoma, Eosinophilic esophagitis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BDNF-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289485 HSALNT0289485]
−
|[[ENST00000499008.3]]
+
|[[INE1]]
−
|BDNF antisense RNA
+
|NCRNA00010
−
|"BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049"
+
|NA
−
|Alzheimer’s disease, Parkinson’s disease and Fragile X syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BLACAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289511 HSALNT0289511]
−
|[[BLACAT1]]
+
|[[LINC01565]]
−
|"linc-UBC1,LINC00912, onco-lncRNA-30"
+
|C3orf27,GR6
−
|bladder cancer associated transcript 1 (non-protein coding)
+
|NA
−
|bladder cancer
+
|pathogenic process
 +
|leukemia
 +
|Neoplasms
 
|-
 
|-
−
|''CAHM''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289068 HSALNT0289068]
−
|[[ENST00000604200.1]]
+
|[[LINC00869]]
−
|LINC00468
+
|KIAA0493
−
|colon adenocarcinoma hypermethylated (non-protein coding)
+
|NA
−
|colorectal neoplasia.
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTCSC1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289430 HSALNT0289430]
−
|[[NONHSAT129210]]
+
|[[ERC2-IT1]]
−
|AK023948
+
|C1orf1,C3orf51,Po42
−
|papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding)
+
|NA
−
|thyroid carcinoma
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BCYRN1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290394 HSALNT0290394]
−
|[[lnc-EPCAM-1:2]]
+
|[[Lnc-PDIA4-1:1]]
−
|"BC200,BC200a, NCRNA00004, LINC00004"
+
|lnc-PDIA4-1:1
−
|"BCYRN1, brain cytoplasmic RNA 1"
+
|NA
−
|Alzheimer's disease
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BPESC1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289195 HSALNT0289195]
−
|[[ENST00000418282.1]]
+
|[[NOP14-AS1]]
−
|NCRNA00187
+
|C4orf10,RES4-24
−
|"blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding)"
+
|NA
−
|blepharophimosis syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CYP4A22-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290309 HSALNT0290309]
−
|[[ENST00000444042.2]]
+
|[[NONHSAT022116]]
−
|"Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506"
+
|NONHSAT022116,AF080092,TSU
−
|CYP4A22 antisense RNA 1
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289243 HSALNT0289243]
−
|[[ENST00000502056.1]]
+
|[[SMAD5-AS1]]
−
|"LINC00860,CARLo-1"
+
|SMAD5O,DAMS
−
|cancer susceptibility candidate 8 (non-protein coding)
+
|NA
−
|Colorectal Cancer,Lung Cancer
+
|pathogenic process
 +
|malignant hematopoietic
 +
|Cell Physiological Phenomena
 
|-
 
|-
−
|''CCAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289025 HSALNT0289025]
−
|[[NONHSAT129017]]
+
|[[LINC00244]]
−
|"CARLo-5, onco-lncRNA-40"
+
|C7orf4,NCRNA00244
−
|colon cancer associated transcript 1 (non-protein coding)
+
|NA
−
|colorectal cancer,gastric cancer
+
|pathogenic process
 +
|preaxial polydactyly
 +
|NA
 
|-
 
|-
−
|''CCAT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289017 HSALNT0289017]
−
|[[CCAT2]]
+
|[[KIF25-AS1]]
−
|"NCCP1, LINC00873"
+
|C6orf54,NCRNA00300,HGC6.1.1
−
|colon cancer associated transcript 2 (non-protein coding)
+
|NA
−
|non-small cell lung cancer
+
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''CISTR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289332 HSALNT0289332]
−
|[[NONHSAT028496]]
+
|[[LINC01558]]
−
|"CISTR-ACT, CISTRACT, re52431"
+
|C6orf123,LINC01557,HGC6.2,dJ431P23.4
−
|chondrogenesis-associated transcript
+
|NA
−
|brachydactyly
+
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''CRNDE''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289438 HSALNT0289438]
−
|[[Lnc-IRX3-4:2]]
+
|[[AFDN-AS1]]
−
|"LOC643911, LINC00180, CRNDEP"
+
|C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3
−
|colorectal neoplasia differentially expressed (non-protein coding)
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CYYR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289232 HSALNT0289232]
−
|[[ENST00000357401.3]]
+
|[[RFPL3S]]
−
|cysteine and tyrosine rich 1 antisense RNA 1
+
|RFPL3-AS1,RFPL3-A, NCRNA00005
−
|N/A
+
|NA
−
|_
+
|pathogenic process
 +
|opitz syndrome
 +
|NA
 
|-
 
|-
−
|''DALIR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289393 HSALNT0289393]
−
|[[DALIR]]
+
|[[RFPL1S]]
−
|DALI
+
|RFPL1-AS1,RFPL1-A, NCRNA00006
−
|DNMT1-associated long intergenic non-coding RNA
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DANCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289500 HSALNT0289500]
−
|[[NONHSAT096369]]
+
|[[HCG4B]]
−
|differentiation antagonizing non-protein coding RNA
+
|HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3
−
|"ANCR, AGU2, lncRNA-ANCR"
+
|NA
−
|bone diseases
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DBET''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289894 HSALNT0289894]
−
|[[NONHSAT099821]]
+
|[[LINC00294]]
−
|"DBE-T, DUX4L30"
+
|NA
−
|D4Z4 binding element transcript (non-protein coding)
+
|NA
−
|Pancreatic ductal adenocarcinoma, Facioscapulohumeral muscular dystrophy
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DHFR upstream transcripts''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289345 HSALNT0289345]
−
|[[NONHSAT102417]]
+
|[[LINC00893]]
−
|"DHFR minor transcript 5'-UTR, ENSG00000228716"
+
|NA
−
|N/A
+
|NA
−
|_
+
|pathogenic process
 +
|hunter syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''DHRS4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290133 HSALNT0290133]
−
|[[NONHSAT035954]]
+
|[[PCBP3-OT1]]
−
|DHRS4 antisense RNA 1
+
|PCBP3-OT1,FLJ44028
−
|"PRO1488,AS1DHRS4"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DLEU1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289488 HSALNT0289488]
−
|[[NONHSAT033797]]
+
|[[ENST00000418282.1]]
−
|deleted in lymphocytic leukemia 1 (non-protein coding)
+
|NCRNA00187
−
|"LEU1, XTP6, NCRNA00021, LINC00021, BCMS1"
+
|NA
−
|chronic lymphocytic leukemia
+
|pathogenic process
 +
|blepharophimosis syndrome
 +
|Eye Diseases
 
|-
 
|-
−
|''DLEU2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289712 HSALNT0289712]
−
|[[NONHSAT033821]]
+
|[[COPG2IT1]]
−
|deleted in lymphocytic leukemia 2 (non-protein coding)
+
|CIT1,NCRNA00170,COPG2AS
−
|"LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG"
+
|NA
−
|chronic lymphocytic leukemia, lymphocytic leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DISC2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265040 HSALNT0265040]
−
|[[NONHSAT010191]]
+
|[[LINC00652]]
−
|"DISC1-AS1, DISC1OS, NCRNA00015"
+
|HSPC072
−
|disrupted in schizophrenia 2 (non-protein coding)
+
|NA
−
|affective disorders, Autism spectrum disorder, bipolar disorder, depression, schizophrenia
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''EGOT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289282 HSALNT0289282]
−
|[[NONHSAT087635]]
+
|[[WASIR2]]
−
|"EGO, ""eosinophil granule ontogeny"", NCRNA00190, ""non-protein coding RNA 190"", ENSG00000235947"
+
|NCRNA00286A
−
|Eosinophil granule ontogeny (EGO) RNA
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''EMX2OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0246856 HSALNT0246856]
−
|[[lnc-PDZD8-3:1]]
+
|[[LINC00470]]
−
|"EMX2-AS1, NCRNA00045, ""non-protein coding RNA 45"",ENSG00000229847"
+
|C18orf2
−
|Emx2 opposite strand transcript.
+
|NA
−
|_
+
|pathogenic process
 +
|age-related macular degeneration
 +
|Eye Diseases
 
|-
 
|-
−
|''ERICD''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289507 HSALNT0289507]
−
|[[Lnc-CHRAC1-2:1]]
+
|[[LINC00588]]
−
|"TCONS_00014875, ERIC"
+
|C8orf71,DKFZP434F122
−
|E2F1-regulated inhibitor of cell death (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ESRG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0276604 HSALNT0276604]
−
|[[ENST00000583516.1]]
+
|[[TTC28-AS1]]
−
|HESRG
+
|TTC28AS,TTC28-AS,KIAA1648
−
|embryonic stem cell related (non-protein coding)
+
|NA
−
|embryonal carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Evf2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237577 HSALNT0237577]
−
|[[lnc-DLX5-3:1]]
+
|[[CDRT7]]
−
|"Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764"
+
|NCRNA00025,LINC00025
−
|_
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FENDRR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288912 HSALNT0288912]
−
|[[FENDRR]]
+
|[[CDRT8]]
−
|FOXF1 adjacent non-coding developmental regulatory RNA
+
|NA
−
|"lincFOXF1, onco-lncRNA-21"
+
|NA
−
|Heart Failure
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FIRRE''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275048 HSALNT0275048]
−
|[[ENST00000427391.1]]
+
|[[CECR3]]
−
|firre intergenic repeating RNA element
+
|NA
−
|LINC01200
+
|NA
−
|_
+
|pathogenic process
 +
|cat eye syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''FOXCUT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288915 HSALNT0288915]
−
|[[Lnc-FOXC1-1:1]],
+
|[[CECR9]]
−
[[NONHSAT106529]]
+
|NA
−
|TCONS_00011636
+
|NA
−
|FOXC1 upstream transcript (non-protein coding)
+
|pathogenic process
−
|esophageal squamous cell carcinoma, basal-like breast cancer
+
|cat eye syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''FTX''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288998 HSALNT0288998]
−
|[[ENST00000602812.1]]
+
|[[HDHD5-AS1]]
−
|"LINC00182,FLJ33139"
+
|CECR4,CECR5-AS1,NCRNA00017
−
|"FTX transcript, XIST regulator (non-protein coding)"
+
|NA
−
|epatocellular carcinoma, colorectal cancer
+
|pathogenic process
 +
|cat eye syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''GHET1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288914 HSALNT0288914]
−
|[[GHET1]]
+
|[[CECR5-AS1]]
−
|lncRNA-GHET1
+
|NCRNA00017
−
|gastric carcinoma proliferation enhancing transcript 1
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|cat eye syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''GHRLOS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288919 HSALNT0288919]
−
|[[NONHSAT087920]]
+
|[[CLRN1-AS1]]
−
|"NCRNA00068,GHRL-AS1"
+
|CLRN1O,UCRP
−
|ghrelin opposite strand/antisense RNA
+
|NA
 +
|pathogenic process
 +
|usher syndrome type 3
 +
|NA
 
|-
 
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289271 HSALNT0289271]
 +
|[[TMEM9B-AS1]]
 +
|C11orf18
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GPR1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289324 HSALNT0289324]
−
|[[NONHSAT076558]]
+
|[[LINC01547]]
−
|GPR1AS
+
|C21orf69,C21orf67
−
|GPR1 antisense RNA
+
|NA
−
|_
+
|pathogenic process
 +
|Down syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''HAGLR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0270409 HSALNT0270409]
−
|[[ENST00000416928.2]],
+
|[[LINC00029]]
−
[[NONHSAT075638]]
+
|C20orf51,NCRNA00029,bA305P22.4
−
|Mdgt
+
|NA
−
|HOXD antisense growth-associated long non-coding RNA
+
|NA
−
|neuroblastoma
+
|NA
 +
|NA
 
|-
 
|-
−
|''HEIH''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289336 HSALNT0289336]
−
|[[HEIH]]
+
|[[LINC00529]]
−
|"LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2"
+
|C8orf8
−
|hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA
+
|NA
−
|hepatocelluar carcinoma
+
|pathogenic process
 +
|keratolytic winter erythema
 +
|NA
 
|-
 
|-
−
|''JADRR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288978 HSALNT0288978]
−
|[[JADRR]]
+
|[[FLVCR1-AS1]]
−
|lncRNA-JADE
+
|FLVCR1-DT,LQK1
−
|JADE1 adjacent regulatory RNA
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KANTR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0238050 HSALNT0238050]
−
|[[ENST00000604849.1]]
+
|[[SMCR2]]
−
|KDM5C adjacent non-coding transcript
+
|NA
−
|Spasm
+
|NA
−
|_
+
|pathogenic process
 +
|Smith-Magenis syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC-PINT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289401 HSALNT0289401]
−
|[[NONHSAT123382]]
+
|[[SMCR5]]
−
|"FLJ43663, PINT, LincRNA-Pint"
+
|NCRNA00034
−
|"long intergenic non-protein coding RNA, p53 induced transcript"
+
|NA
−
|pancreatic cancer
+
|pathogenic process
 +
|Smith-Magenis syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC00163''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290246 HSALNT0290246]
−
|[[LINC00163]]
+
|[[SMCR6]]
−
|"NLC1-A, NLC1A"
+
|NA
−
|long intergenic non-protein coding RNA 163
+
|NA
−
|_
+
|pathogenic process
 +
|Smith-Magenis syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC00312''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274626 HSALNT0274626]
−
|[[NONHSAT087716]]
+
|[[LINC00205]]
−
|"NAG7, NAG-7, ERR10, LMCD1DN, ERR-10"
+
|C21orf86,NCRNA00205,
−
|long intergenic non-protein coding RNA 312
+
|NA
−
|nasopharyngeal carcinoma
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00850''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271512 HSALNT0271512]
−
|[[LINC00850]]
+
|[[C21orf91-OT1]]
−
|KUCG1
+
|NCRNA00285,D21S2089E
−
|long intergenic non-protein coding RNA 850
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC01191''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0272596 HSALNT0272596]
−
|[[ENST00000412690.1]]
+
|[[LINC00307]]
−
|"VIN, lnc-ACTR3"
+
|NCRNA00307,D21S2091E
−
|long intergenic non-protein coding RNA 1191
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LSINCT5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274502 HSALNT0274502]
−
|[[LSINCT5]]
+
|[[TSPEAR-AS2]]
−
|N/A
+
|C21orf90
−
|long stress-induced non-coding transcript 5
+
|NA
−
|gastric cancer,breast and ovarian cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LUCAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274807 HSALNT0274807]
−
|[[ENST00000511918.1]]
+
|[[MCM3AP-AS1]]
−
|SCAL1
+
|C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031
−
|lung cancer associated transcript 1 (non-protein coding)
+
|NA
−
|non-small cell lung cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR22HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288888 HSALNT0288888]
−
|[[ENST00000574306.1]]
+
|[[B3GALT5-AS1]]
−
|"MGC14376, DKFZp686O06159, LOC554202"
+
|C21orf88
−
|MIR22 host gene
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR31HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288898 HSALNT0288898]
−
|[[NONHSAT130385]]
+
|[[BRWD1-AS2]]
−
|LOC554202
+
|C21orf87,NCRNA00257,BRWD1-IT2
−
|MIR31 host gene
+
|NA
−
|gastric cancer, pancreatic ductal adenocarcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR99AHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289031 HSALNT0289031]
−
|[[ENST00000602580.1]]
+
|[[LINC00315]]
−
|MONC
+
|C21orf93,NCRNA00315
−
|mir-99a-let-7c cluster host gene
+
|NA
−
|myeloid leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR100HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289033 HSALNT0289033]
−
|[[ENST00000531381.1]]
+
|[[LINC00334]]
−
|"AGD1, lncRNA-N2"
+
|C21orf89,NCRNA00334
−
|mir-100-let-7a-2 cluster host gene
+
|NA
−
|myeloid leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR155HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289322 HSALNT0289322]
−
|[[NONHSAT081499]]
+
|[[LINC00314]]
−
|"BIC, NCRNA00172"
+
|C21orf94,NCRNA00314
−
|MIR155 host gene
+
|NA
−
|chronic lymphocytic leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR222HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0271821 HSALNT0271821]
−
|[[ENST00000602507.1]]
+
|[[LINC00308]]
−
|Lnc-Ang362
+
|C21orf74,NCRNA00308,PRED16
−
|MIR222 host gene
+
|NA
−
|Ang II-associated cardiovascular disease
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIR503HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289023 HSALNT0289023]
−
|[[ENST00000414769.1]]
+
|[[LINC00189]]
−
|"MGC16121, H19X"
+
|C21orf109,NCRNA00189
−
|MIR503 host gene
+
|NA
−
|choriocarcinoma
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MYCNUT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289375 HSALNT0289375]
−
|[[ENST00000433810.1]]
+
|[[NCRUPAR]]
−
|lncUSMycN
+
|ncR-uPAR,ncRuPAR,NCRNA00193
−
|MYCN upstream transcript (non-protein coding)
+
|transcriptional regulation
−
|neuroblastoma
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NAMA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273467 HSALNT0273467]
−
|[[ENST00000604258.1]]
+
|[[DSCR10]]
−
|N/A
+
|NA
−
|"non-protein coding RNA, associated with MAP kinase pathway and growth arrest"
+
|NA
−
|papillary thyroid carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NRIR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289480 HSALNT0289480]
−
|[[ENST00000414795.1]]
+
|[[DSCR9]]
−
|lncRNA-CMPK2
+
|NCRNA00038
−
|negative regulator of interferon response (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''OIP5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290051 HSALNT0290051]
−
|[[ENST00000500949.2]]
+
|[[MDS2]]
−
|"cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1"
+
|NA
−
|OIP5 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|myelodysplastic syndrome
 +
|Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''OVAAL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127810 HSALNT0127810]
−
|[[ENST00000442621.1]]
+
|[[ST7-AS2]]
−
|"LINC01131,OVAL"
+
|ST7OT2,ST7AS2
−
|ovarian adenocarcinoma amplified long non-coding RNA
+
|NA
−
|ovarian cancer
+
|pathogenic process
 +
|autism
 +
|Mental Disorders
 
|-
 
|-
−
|''PACERR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0127813 HSALNT0127813]
−
|[[ENST00000608917.1]]
+
|[[ST7-OT3]]
−
|"PACER, PTGS2-AS1"
+
|ST7OT3,NCRNA00026
−
|PTGS2 antisense NFKB1 complex-mediated expression regulator RNA
+
|NA
−
|inflammation and cancer
+
|pathogenic process
 +
|autism
 +
|Mental Disorders
 
|-
 
|-
−
|''PART1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290258 HSALNT0290258]
−
|[[ENST00000506884.1]]
+
|[[ST7-OT4]]
−
|"DKFZP586D0823, NCRNA00206"
+
|NA
−
|prostate androgen-regulated transcript 1 (non-protein coding)
+
|NA
−
|prostate carcinogenesis
+
|pathogenic process
 +
|autism
 +
|Mental Disorders
 
|-
 
|-
−
|''PAUPAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290257 HSALNT0290257]
−
|[[NONHSAT018635]]
+
|[[NONHSAT122926]]
−
|N/A
+
|NONHSAT122926
−
|PAX6 upstream antisense RNA
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCA3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289372 HSALNT0289372]
−
|[[ENST00000412654.1]]
+
|[[MIR600HG]]
−
|"DD3, NCRNA00019, PCAT3"
+
|C9orf45,NCRNA00287,GL012,FLJ22161
−
|prostate cancer associated 3 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013239 HSALNT0013239]
−
|[[ENST00000561978.1]]
+
|[[ATP1A1-AS1]]
−
|"PCAT-1, PCA1"
+
|C1orf203,ATP1A1OS,MGC16179
−
|prostate cancer associated transcript 1 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0048563 HSALNT0048563]
−
|[[ENST00000504263.1]]
+
|[[SPATA3-AS1]]
−
|"GDEP, PCAN1, PCA4"
+
|NA
−
|prostate cancer associated transcript 4 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050859 HSALNT0050859]
−
|[[ENST00000452148.2]]
+
|[[LINC00852]]
−
|PCAN-R2
+
|C3orf42,GHRLOS2,NAG73,GHRL-AS2
−
|prostate cancer associated transcript 7 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PRNCR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0069395 HSALNT0069395]
−
|[[NONHSAT129019]]
+
|[[LINC01096]]
−
|N/A
+
|NA
−
|prostate cancer associated non-coding RNA 1
+
|NA
−
|Prostate Cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTCSC2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072367 HSALNT0072367]
−
|[[ENST00000430058.1]]
+
|[[LINC02260]]
−
|N/A
+
|NA
−
|papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding)
+
|NA
−
|papillary thyroid carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTCSC3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0077259 HSALNT0077259]
−
|[[ENST00000556013.2]]
+
|[[LINC01091]]
−
|N/A
+
|NA
−
|papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding)
+
|NA
−
|psoriasis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PVT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0096480 HSALNT0096480]
−
|[[ENST00000513868.2]]
+
|[[SAP30L-AS1]]
−
|"NCRNA00079, LINC00079, onco-lncRNA-100"
+
|FLJ38109,GALNT10-AS1
−
|Pvt1 oncogene (non-protein coding)
+
|NA
−
|neuroblastoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PWRN1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0098558 HSALNT0098558]
−
|[[NONHSAT040920]]
+
|[[PRR7-AS1]]
−
|NCRNA00198
+
|NA
−
|Prader-Willi region non-protein coding RNA 1
+
|NA
−
|Prader-Willi syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PWRN2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0099356 HSALNT0099356]
−
|[[NONHSAT040875]]
+
|[[LINC01622]]
−
|NCRNA00199
+
|TCONS_00011202
−
|Prader-Willi region non-protein coding RNA 2
+
|NA
−
|Prader-Willi syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''RASSF1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0113415 HSALNT0113415]
−
|[[RASSF1-AS1]]
+
|[[LINC01312]]
−
|RASSF1 antisense RNA 1
+
|MGC34034
−
|ANRASSF1
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SCAANT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0134652 HSALNT0134652]
−
|[[SCAANT1]]
+
|[[EXTL3-AS1]]
−
|SCA7/ATXN7 antisense RNA 1
+
|C8orf50
−
|ATXN7-AS1
+
|NA
−
|Spinocerebellar ataxia type 7
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SCHLAP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0138253 HSALNT0138253]
−
|[[NONHSAT075852]]
+
|[[C8orf34-AS1]]
−
|SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding)
+
|NA
−
|"SChLAP1,PCAT11"
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SENCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154876 HSALNT0154876]
−
|[[ENST00000526269.2]]
+
|[[PSMD5-AS1]]
−
|smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA
+
|NA
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TARID''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0163228 HSALNT0163228]
−
|[[ENST00000607033.1]]
+
|[[LINC01553]]
−
|N/A
+
|C10orf40,AC023904.2
−
|TCF21 antisense RNA inducing promoter demethylation
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''WFDC21P''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175689 HSALNT0175689]
−
|[[Lnc-HEATR6-1:4]]
+
|[[LINC00301]]
−
|"WAP four-disulfide core domain 21, pseudogene"
+
|C11orf64,NCRNA00301,MGC39681
−
|"LOC645638, lnc-DC, LNCDC"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GAS5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0247235 HSALNT0247235]
−
|[[NONHSAT007663]]
+
|[[DLGAP1-AS3]]
−
|"SNHG2, ENSG00000234741"
+
|NA
−
|_
+
|NA
−
|autoimmune disease, breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MIAT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0254200 HSALNT0254200]
−
|[[lnc-CRYBA4-2:1]]
+
|[[CIRBP-AS1]]
−
|"FLJ25967, gomafu, LINC00066, lncRNA-MIAT, ""long intergenic non-protein coding RNA 66"", NCRNA00066, ""non-protein coding RNA 66"", Rncr2"
+
|C19orf23,MGC39338
−
|myocardial infarction associated transcript (non-protein coding)
+
|NA
−
|myocardial infarction
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''H19''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257335 HSALNT0257335]
−
|[[NONHSAT017465]]
+
|[[LINC01785]]
−
|"Q96MK8,ENSG00000130600"
+
|NA
−
|"H19, imprinted maternally expressed transcript (non-protein coding)"
+
|NA
−
|bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HAR1A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0261582 HSALNT0261582]
−
|[[lnc-BIRC7-2:1]]
+
|[[LINC01869]]
−
|"HAR1F, ENSG00000238820"
+
|MGC45922
−
|highly accelerated region 1A
+
|NA
−
|Huntington's disease
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HAR1B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0269743 HSALNT0269743]
−
|[[ENST00000447910.2]]
+
|[[LINC01711]]
−
|"HAR1R, ENSG00000231133"
+
|MGC4294
−
|highly accelerated region 1B
+
|NA
−
|Huntington's disease
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOTAIR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288468 HSALNT0288468]
−
|[[NONHSAT028508]]
+
|[[FAM41AY1]]
−
|"Gm16258, Hox antisense intergenic RNA, ENSG00000228630"
+
|FAM41AY
−
|Hox antisense intergenic RNA
+
|NA
−
|B-cell neoplasms,breast cancer,cervical cancer,colon cancer,colorectal cancer,endometrial cancer,gastric cancer,hepatocelluar carcinoma,laryngeal squamous cell carcinoma,liver cancer,lung adenocarcinoma,nasopharyngeal carcinoma,non-small cell lung cancer,oesophageal squamous cell carcinoma,oral squamous cell carcinoma,pancreas cancer,rheumatoid arthritis,small cell lung cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOTAIRM1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288899 HSALNT0288899]
−
|[[lnc-EVX1-12:1]]
+
|[[C5orf66-AS2]]
−
|"HIT06113, HIT92376, linc1548, ENSG00000233429"
+
|NA
−
|"HOXA transcript antisense RNA, myeloid-specific 1"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOTTIP''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288922 HSALNT0288922]
−
|[[NONHSAT119717]]
+
|[[CSTF3-AS1]]
−
|"HOXA13as, HIT18844, NCRNA00213, ENSG00000243766"
+
|CSTF3-DT
−
|HOXA transcript at the distal tip
+
|NA
−
|hepatocelluar carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOXA11-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288923 HSALNT0288923]
−
|[[NONHSAT119704]]
+
|[[CYP1B1-AS1]]
−
|"HOXA cluster antisense RNA 5 (non-protein coding), HOXA-AS5, ""HOXA11 antisense RNA 1 (non-protein coding)"", HOXA11-AS1, HOXA11S, NCRNA00076, ""non-protein coding RNA 76"", ENSG00000240990"
+
|C2orf58,MGC34824
−
|HOXA11 antisense RNA
+
|NA
−
|glioma, ovarian cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOXA-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288957 HSALNT0288957]
−
|[[NONHSAT119676]]
+
|[[ENTPD3-AS1]]
−
|"HOXA3as, ENSG00000253552"
+
|FLJ36665
−
|HOXA cluster antisense RNA 2
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HOXA-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288970 HSALNT0288970]
−
|[[lnc-EVX1-9:1]]
+
|[[FAM27E3]]
−
|HOXA6as
+
|MGC42630
−
|HOXA cluster antisense RNA 3
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HULC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288972 HSALNT0288972]
−
|[[NONHSAT107640]]
+
|[[FAM41C]]
−
|ENSG00000251164
+
|NA
−
|hepatocellular carcinoma up-regulated long non-coding RNA
+
|NA
−
|hepatocelluar carcinoma, liver cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''IPW''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288977 HSALNT0288977]
−
|[[NONHSAT041063]]
+
|[[FLG-AS1]]
−
|NCRNA00002
+
|NA
−
|imprinted in Prader-Willi syndrome
+
|NA
−
|Prader-Willi syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''JPX''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288983 HSALNT0288983]
−
|[[lnc-ZCCHC13-1:1]]
+
|[[GABPB1-IT1]]
−
|"DCBALD06, ENOX, ""expressed neighbor of XIST"", ""just proximal to XIST"", LINC00183"
+
|FLJ10038
−
|"JPX transcript, XIST activator (non-protein coding)"
+
|NA
−
|X chromosome inactivatio
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KCNQ1OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289010 HSALNT0289010]
−
|[[NONHSAT017524]]
+
|[[ILF3-AS1]]
−
|"KCNQ1 antisense RNA 2 (non-protein coding), ""KCNQ1 overlapping transcript 1 (non-protein coding)"", KCNQ1-AS2, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012, ""non-protein coding RNA 12"""
+
|ILF3-DT
−
|KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)
+
|NA
−
|Beckwith-Wiedemann syndrome,colorectal cancer,hepatocelluar carcinoma,kidney cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KRASP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289034 HSALNT0289034]
−
|[[NONHSAT113225]]
+
|[[LINC00347]]
−
|ENSG00000220635
+
|NA
−
|KRAS Pseudogene 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FALEC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289039 HSALNT0289039]
−
|[[ENST00000416894.1]]
+
|[[LINC00466]]
−
|"LINC00568, ""long intergenic non-protein coding RNA 568"", ENSG00000228126.1"
+
|NA
−
|focally amplified long non-coding RNA in epithelial cancer
+
|NA
−
|ovarian cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''lincRNA-ROR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289040 HSALNT0289040]
−
|[[NONHSAT059436]]
+
|[[LINC00471]]
−
|"ROR, lincRNA-ST8SIA3, ENSG00000258609"
+
|C2orf52,MGC43122
−
|"long intergenic non-protein coding RNA, regulator of reprogramming"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LOC100887755''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289044 HSALNT0289044]
−
|[[lnc-SNAI1-1:1]]
+
|[[LINC00526]]
−
|"Noncoding RNA activating7: ncRNA-a7, ENST00000431460.1,ENSG00000231265,TRERNA1"
+
|C18orf18,MGC17515,HsT959
−
|translation regulatory long non-coding RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TUSC7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289048 HSALNT0289048]
−
|[[NONHSAT091315]]
+
|[[LINC00593]]
−
|"LINC00902, LOC285194, ENSG00000243197"
+
|C15orf50,MGC42951
−
|tumor suppressor candidate 7 (non-protein coding)
+
|NA
−
|colorectal cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''RBM5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289050 HSALNT0289050]
−
|[[NONHSAT089783]]
+
|[[LINC00608]]
−
|"LUCA-15-specific transcript, LUST, ENSG00000003756"
+
|NA
−
|RBM5 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MALAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289054 HSALNT0289054]
−
|[[ENST00000534336.1]]
+
|[[LINC00638]]
−
|"HCN, ""hepcarcin"", LINC00047, ""long intergenic non-protein coding RNA 47"", MALAT-1, mascRNA, ""metastasis associated in lung adenocarcinoma transcript 1"", NCRNA00047, NEAT2, ""non-protein coding RNA 47"", ""nuclear enriched abundant transcript 2"", ""nuclear paraspeckle assembly transcript 2 (non-protein coding)"", PRO1073, ENSG00000251562"
+
|MGC23270
−
|metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
+
|NA
−
|B-cell neoplasms,bladder cancer,breast cancer, cervial cancer, colon cancer, decreased myogenesis,Diabetes, endometrial cancer, gallbladder cancer, hepatocelluar carcinoma, kidney cancer, laryngeal squamous cell carcinoma, liver cancer, lung cancer, nasopharyngeal carcinoma, neuroblastoma, non-small cell lung cancer, osteosarcoma, pancreas cancer, prostate cancer, small cell lung cancer, uterus cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''mascRNA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289056 HSALNT0289056]
−
|[[lnc-SCYL1-1:5]]
+
|[[LINC00661]]
−
|Malat1
+
|NA
−
|mascRNA (MALAT1-associated small cytoplasmic RNA)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MEG3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289057 HSALNT0289057]
−
|[[NONHSAT039745]]
+
|[[LINC00662]]
−
|"Gtl2, ENSG00000214548"
+
|NA
−
|maternally expressed 3 (non-protein coding)
+
|NA
−
|bladder cancer, breast cancer, chronic myeloid leukemia, colon cancer, gastric cancer, glioma, hepatocelluar carcinoma, heroin abuse, Huntington's disease, kidney cancer, lung cancer, Meningioma, myelodysplastic syndrome, nonfunctioning pituitary adenomas, Pituitary adenoma, prostate cancer, type 1 diabetes
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ncR-PAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289062 HSALNT0289062]
−
|[[NONHSAT102247]]
+
|[[LINC00692]]
−
|"NCRUPAR, ENSG00000225407"
+
|NA
−
|"non-protein coding RNA, upstream of F2R/PAR1"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NDM29''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289064 HSALNT0289064]
−
|[[lnc-C11orf16-1:1]]
+
|[[LINC00705]]
−
|29A
+
|NA
−
|"neuroblastoma differentiation marker 29 (Castelnuovo (2010), Pagano (2007))."
+
|NA
−
|neuroblastoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GNAS-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289067 HSALNT0289067]
−
|[[lnc-CTSZ-5:1]]
+
|[[LINC00868]]
−
|"GNAS antisense, GNAS1AS, NCRNA00075, NESP-AS, NESPAS, ""non-protein coding RNA 75"", SANG, ENSG00000235590"
+
|C17orf52
−
|neuroendocrine secretory protein (Nesp) antisense.
+
|NA
−
|pseudohypoparathyroidism type Ib
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NRON''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0130693 HSALNT0130693]
−
|[[NONHSAT134764]]
+
|[[LINC00996]]
−
|ENSG00000253079
+
|NA
−
|"non-protein coding RNA, repressor of NFAT"
+
|NA
−
|AIDS
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NTT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289101 HSALNT0289101]
−
|[[NONHSAT115106]]
+
|[[LINC01252]]
−
|N/A
+
|NA
−
|noncoding transcript in T cells.
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''OTX2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289131 HSALNT0289131]
−
|[[lnc-C14orf101-5:1]]
+
|[[LINC02135]]
−
|"OTX2OS1, ENSG00000248550"
+
|NA
−
|OTX2 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PANDAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289193 HSALNT0289193]
−
|[[lnc-CDKN1A-1:1]]
+
|[[NIFK-AS1]]
−
|"P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR"
+
|NA
−
|promoter of CDKN1A antisense DNA damage activated RNA
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PCGEM1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289244 HSALNT0289244]
−
|[[NONHSAT076153]]
+
|[[SMG7-AS1]]
−
|ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA
+
|DKFZP564C196
−
|Prostate-specific transcript 1
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00853''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0235326 HSALNT0235326]
−
|[[ENST00000429328.2]]
+
|[[SNAI3-AS1]]
−
|"PDZK1IP1 antisense RNA 1 (non-protein coding), ""PDZK1IP1 antisense RNA 1 (tail to tail)"", PDZK1IP1-AS1 ,ENSG00000224805"
+
|MGC23284
−
|long intergenic non-protein coding RNA 853
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PRINS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215205 HSALNT0215205]
−
|[[NONHSAT011777]]
+
|[[SNHG10]]
−
|ENSG00000238115
+
|C14orf62,FLJ40557,NCRNA00063,LINC00063
−
|Psoriasis susceptibility-related RNA Gene Induced by Stress
+
|NA
−
|psoriasis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PTENP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289290 HSALNT0289290]
−
|[[NONHSAT130775]]
+
|[[ZNF205-AS1]]
−
|"PTENpg1, PTEN2, ENSG00000237984"
+
|MGC3771
−
|PTEN Pseudogene 1
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''MEG8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289294 HSALNT0289294]
−
|[[ENST00000553584.1]]
+
|[[LINC00260]]
−
|"Bsr, ""Imprinted RNA near Meg3/Gtl2"", Irm, LINC00024, ""long intergenic non-protein coding RNA 24"", NCRNA00024, ""non-protein coding RNA 24"", Rian, ""RNA Imprinted and Accumulated in Nucleus"", ENSG00000258399"
+
|C1orf217,NCRNA00260,MGC5457
−
|Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8
+
|NA
−
|Prader-Willi/Angelman syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00599''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289295 HSALNT0289295]
−
|[[lnc-TNKS-1:1]]
+
|[[LINC00337]]
−
|"retinal non-coding RNA 3, Rncr3, ENSG00000253230"
+
|C1orf211,NCRNA00337,MGC40168
−
|"Retinal noncoding RNA 3, long intergenic non-protein coding RNA 599"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FAS-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289298 HSALNT0289298]
−
|[[NONHSAT015489]]
+
|[[WAC-AS1]]
−
|"SAF, ENSG00000026103"
+
|NA
−
|FAS antisense RNA 1
+
|NA
−
|B-cell lymphoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ATXN8OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289299 HSALNT0289299]
−
|[[NONHSAT034251]]
+
|[[LINC00839]]
−
|"NCRNA00003, ""non-protein coding RNA 3"", ATXN8OS, KLHL1AS, SCA8, ENSG00000230223"
+
|NA
−
|Spinocerebellar ataxia 8 (SCA8) RNA;KLHL1AS: kelch-like 1 (Drosophila) antisense;ATXN8OS: ataxin 8 opposite strand
+
|NA
−
|human spinocerebellar ataxia type 8,Spinocerebellar ataxia type 8
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289303 HSALNT0289303]
−
|[[NONHSAT021826]]
+
|[[LINC00612]]
−
|"UHG, ENSG00000255717"
+
|C12orf33,MGC40170,FLJ41814
−
|SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene.
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289312 HSALNT0289312]
−
|[[lnc-OR10H5-1:1]]
+
|[[LINC00663]]
−
|"U17HG, linc1343, ENSG00000242125"
+
|MGC39821
−
|Small nucleolar RNA host gene 3
+
|NA
−
|Alzheimer's disease
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289320 HSALNT0289320]
−
|[[NONHSAT104072]]
+
|[[LINC00494]]
−
|"U19H, ENSG00000200959"
+
|NA
−
|Small nucleolar RNA host gene 4
+
|NA
−
|myelodysplastic syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289330 HSALNT0289330]
−
|[[NONHSAT054526]]
+
|[[LINC01019]]
−
|"U50HG, ENSG00000203875"
+
|NA
−
|Small nucleolar RNA host gene 5
+
|NA
−
|lymphoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SNHG6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289333 HSALNT0289333]
−
|[[lnc-TCF24-2:3]]
+
|[[LINC00265]]
−
|"U87HG, ENSG00000245910"
+
|NCRNA00265,NCRNA00265-1
−
|Small nucleolar RNA host gene 6
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SPRY4-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289334 HSALNT0289334]
−
|[[lnc-NDFIP1-3:1]]
+
|[[LINC00689]]
−
|"AK024556, ENSG00000274721"
+
|NA
−
|SPRY4 intronic transcript 1 (non-protein coding)
+
|NA
−
|melanoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SRA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289337 HSALNT0289337]
−
|[[lnc-SRA1-1:1]]
+
|[[LINC01591]]
−
|"SRA1, ENSG00000213523"
+
|NA
−
|Steroid receptor RNA Activator
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TEA-ncRNAs''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289340 HSALNT0289340]
−
|[[NONHSAT035776]]
+
|[[LINC01501]]
−
|ENSG00000251002
+
|NA
−
|T early alpha
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''IFNG-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289346 HSALNT0289346]
−
|[[ENST00000538665.1]]
+
|[[LINC01560]]
−
|"LincR-Ifng-3'AS, NEST, "Theiler's murine encephalomyelitis virus persistence candidate gene 1", Tmevpg1, ENSG00000255733"
+
|CXorf24
−
|IFNG antisense RNA 1
+
|NA
−
|multiple sclerosis
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TncRNA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289352 HSALNT0289352]
−
|[[NONHSAT022116]]
+
|[[LINC01959]]
−
|TSU
+
|NA
−
|TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA).
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TUG1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289353 HSALNT0289353]
−
|[[NONHSAT084827]]
+
|[[LINC02175]]
−
|ENSG00000253352
+
|NA
−
|taurine up-regulated gene 1
+
|NA
−
|B-cell neoplasms, bladder cancer, Huntington's disease, non-small cell lung cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''UCA1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289354 HSALNT0289354]
−
|[[lnc-OR10H5-1:1]]
+
|[[LINC02209]]
−
|"UCA1a, CUDR, UCAT1, LINC00178, NCRNA00178, GCAP2, GUCA1B, GUCA2, RP48, ENSG00000214049"
+
|FAM183CP
−
|urothelial cancer associated 1 (non-protein coding)
+
|NA
−
|bladder cancer, oral squamous cell carcinoma, pancreaticobiliary maljunction, squamous carcinoma,  tongue squamous cell carcinomas
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KCNIP4-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289359 HSALNT0289359]
−
|[[NONHSAT095745]]
+
|[[LINGO1-AS1]]
−
|"non coding transcript UM9(5), UM9-5"
+
|NA
−
|KCNIP4 intronic transcript 1 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''WT1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289362 HSALNT0289362]
−
|[[lnc-EIF3M-1:1]]
+
|[[MAFG-AS1]]
−
|"WIT1, ENSG00000183242"
+
|MAFG-DT
−
|WT1 (Wilms' tumor 1) antisense transcript
+
|NA
−
|gastric cancer, hepatocellular carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''XIST''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289373 HSALNT0289373]
−
|[[NONHSAT137541]]
+
|[[MORF4L2-AS1]]
−
|ENSG00000229807
+
|NA
−
|X inactive-specific transcript
+
|NA
−
|Trisomy 21, bladder cancer, breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ZEB2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289381 HSALNT0289381]
−
|[[NONHSAT074775]]
+
|[[NPHP3-AS1]]
−
|"Zeb2NAT, ENSG00000238057"
+
|NCRNA00119
−
|Zeb2 natural antisense transcript
+
|NA
−
|bladder cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ZFAS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289385 HSALNT0289385]
−
|[[NONHSAT080206]]
+
|[[PAXIP1-AS1]]
−
|"Znfx1 antisense, 1500012F01Rik, NCRNA00275, ENSG00000177410"
+
|NA
−
|ZNFX1 antisense RNA 1
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Zfhx2as''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289413 HSALNT0289413]
−
|[[ENST00000554403.1]]
+
|[[TOLLIP-AS1]]
−
|"Zfh-5AS, ENSG00000157306"
+
|NA
−
|"zinc finger homeobox 2, antisense"
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289416 HSALNT0289416]
 +
|[[LINC00311]]
 +
|TMEM148,NCRNA00311,MGC22001
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''TMEM161B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289422 HSALNT0289422]
−
|[[lnc-RASA1-3:23]],
+
|[[ZNF252P-AS1]]
−
[[lnc-RASA1-3:25]]
+
|C8orf77
−
|"AK082072,linc-POLR3G-8, ENSG00000247828"
+
|NA
−
|TMEM161B antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''Alpha 250/ Alpha 280''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289423 HSALNT0289423]
−
|[[NONHSAT104559]],
+
|[[ZNF436-AS1]]
−
[[lnc-NDST1-1:2]]
+
|C1orf213,FLJ90508
−
|N/A
+
|NA
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''CDKN2B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289429 HSALNT0289429]
−
|[[NONHSAT130421]],
+
|[[BFSP2-AS1]]
−
[[lnc-C9orf53-2:1]]
+
|MGC2848
−
|"ANRIL, p15AS, ENSG00000240498"
+
|NA
−
|CDKN2B antisense RNA 1
+
|NA
−
|abdominal aortic aneurysm,acute lymphoblastic leukemia,basal cell carcinoma,breast cancer,cardiovascular disease,coronary artery disease,coronary heart disease,Diabetes,endometriosis,Esophageal squamous cell cancer,gastric cancer,glioma,hereditary cutaneous malignant melanoma,intracranial aneurism,ischemic stroke,melanoma,myocardial infarction,nasopharyngeal carcinoma,neural system tumors syndrome,Neurofibromatosis type 1,periodontitis,prostate cancer,
+
|NA
 +
|NA
 
|-
 
|-
−
|''BACE1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289432 HSALNT0289432]
−
|[[NONHSAT024403]],[[lnc-RNF214-1:2]]
+
|[[CTBP1-DT]]
−
|"BACE1AS,NCRNA00177; FJ573250"
+
|C4orf42,CTBP1-AS1,CTBP1-DT,MGC21675
−
|BACE1 antisense RNA
+
|NA
−
|Alzheimer's disease,
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Beta-globin transcripts''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289436 HSALNT0289436]
−
|[[NONHSAT017676]],
+
|[[EXOC3-AS1]]
−
[[NONHSAT017675]],
+
|C5orf55
−
[[NONHSAT017674]]
+
|NA
−
|N/A
+
|NA
−
|N/A
+
|NA
−
|_
+
|NA
 
|-
 
|-
−
|''LINC00581''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289441 HSALNT0289441]
−
|[[lnc-PRL-6:2]],
+
|[[HCG27]]
−
[[lnc-PRL-6:1]]
+
|bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123
−
|"BX118339,Hs.112750, linc-MBOAT1-4: TCONS_00012107, linc-MBOAT1-4: TCONS_00012678"
+
|NA
−
|long intergenic non-protein coding RNA 581
+
|NA
−
|West Syndrome
+
|NA
 +
|NA
 
|-
 
|-
−
|''CAR Intergenic 10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289450 HSALNT0289450]
−
|[[NONHSAT016928]],
+
|[[BAALC-AS2]]
−
[[lnc-FANK1-3:1]]
+
|C8orf56,BAALCOS,MGC39526
−
|"Intergenic10, CR611911, AK055628"
+
|NA
−
|Chromatin Associated RNA 10
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''DIO3OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289453 HSALNT0289453]
−
|[[NONHSAT040032]],
+
|[[FAM87A]]
−
[[NONHSAT040039]]
+
|NA
−
|"DIO3-AS1, NCRNA00041, ""non-protein coding RNA 41"", ENSG00000258498"
+
|NA
−
|DIO3 opposite strand/antisense RNA (head to head)
+
|NA
−
|_
+
|NA
 +
|NA
 
|-
 
|-
−
|''PCAT6''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289459 HSALNT0289459]
−
|[[PCAT6]]
+
|[[JMJD1C-AS1]]
−
|"Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288"
+
|NA
−
|N/A
+
|NA
−
|prostate cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00570''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289465 HSALNT0289465]
−
|[[ENST00000417473.2]]
+
|[[ATP2B1-AS1]]
−
|"KDM5BAS1, ncRNA-a2, onco-lncRNA-96, PCAN-R1, ""prostate cancer-associated noncoding RNA 1"",ENSG00000224177,"
+
|LINC00936
−
|prostate cancer associated transcript 6 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''NEAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289466 HSALNT0289466]
−
|[[ENST00000501122.2]],
+
|[[CEP83-AS1]]
−
[[NONHSAT022111]]
+
|CEP83-DT
−
|"MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532"
+
|NA
−
|Nuclear enriched abundant transcript 1.
+
|NA
−
|infertility
+
|NA
 +
|NA
 
|-
 
|-
−
|''ST7OT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289470 HSALNT0289470]
−
|[[NONHSAT122926]],
+
|[[HEXA-AS1]]
−
[[NONHSAT122918]],
+
|C15orf34,FLJ13315
−
[[NONHSAT122914]],
+
|NA
−
[[NONHSAT122932]]
+
|NA
−
|"ST7OT1, ST7OT2, ST7OT3, ST7OT4, ST7AS1, ST7AS2, ST7AS3, ST7AS4, ENSG00000214188"
+
|NA
−
|N/A
+
|NA
−
|_
 
 
|-
 
|-
−
|''snaR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289487 HSALNT0289487]
−
|[[lnc-BSPH1-1:1]],[[lnc-BSPH1-2:1]]
+
|[[BIN3-IT1]]
−
|small NF90-associated RNAs
+
|FLJ14107
−
|small NF90-associated RNAs
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Y RNAs''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289490 HSALNT0289490]
−
|[[lnc-PDIA4-1:1]]
+
|[[CSNK1G2-AS1]]
−
|N/A
+
|C19orf34,MGC39696
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''PR antisense transcripts''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289508 HSALNT0289508]
−
|[[NONHSAT023851]]
+
|[[LINC00634]]
−
|N/A
+
|NA
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''FAM3D-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289510 HSALNT0289510]
−
|[[FAM3D-AS1]]
+
|[[LINC00685]]
−
|lnc-KCTD6-3
+
|CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574
−
|FAM3D antisense RNA 1
+
|NA
−
|head and neck squamous cell carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''SHANK2-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289515 HSALNT0289515]
 
|[[SHANK2-AS3]]
 
|[[SHANK2-AS3]]
−
|N/A
+
|C11orf76
−
|SHANK2 antisense RNA 3
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''AATBC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290073 HSALNT0290073]
−
|[[AATBC]]
+
|[[NCBP2-AS2]]
−
|N/A
+
|NA
−
|apoptosis associated transcript in bladder cancer
+
|NA
−
|bladder cancer
+
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289502 HSALNT0289502]
 +
|[[NONHSAT095745]]
 +
|NCRNA00099,UM9-5
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289856 HSALNT0289856]
 +
|[[GTSCR1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|Gilles de la Tourette syndrome
 +
|Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''ABHD11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289325 HSALNT0289325]
−
|[[ABHD11-AS1]]
+
|[[LINC00272]]
−
|NCRNA00035
+
|C1orf120,NCRNA00272,RP1-223H12.3
−
|ABHD11 antisense RNA 1 (tail to tail)
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''ABHD15-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288512 HSALNT0288512]
−
|[[ABHD15-AS1]]
+
|[[TTTY9B]]
−
|"linc-TP53I13, lnc-TP53I13"
+
|NCRNA00132
−
|ABHD15 antisense RNA 1
+
|NA
−
|cardiometabolic diseases
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ACTA2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290155 HSALNT0290155]
−
|[[ACTA2-AS1]]
+
|[[Prion-associated RNAs]]
−
|"uc001kfo.1, ZXF1"
+
|NA
−
|ACTA2 antisense RNA 1
+
|NA
−
|lung adenocarcinoma
+
|pathogenic process
 +
|prion disease
 +
|Nervous System Diseases
 
|-
 
|-
−
|''ADAMTS9-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289444 HSALNT0289444]
−
|[[ADAMTS9-AS2]]
+
|[[BLACE]]
−
|N/A
+
|NA
−
|ADAMTS9 antisense RNA 2
+
|NA
−
|glioma
+
|pathogenic process
 +
|acute B lymphoblastic leukemias
 +
|Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''ADORA2A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0060411 HSALNT0060411]
−
|[[ADORA2A-AS1]]
+
|[[H1FX-AS1]]
−
|FLJ34651
+
|C3orf47,FLJ34151
−
|ADORA2A antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''AFAP1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0186668 HSALNT0186668]
−
|[[AFAP1-AS1]]
+
|[[LINC00477]]
−
|MGC10981
+
|C12orf67,FLJ32894,FAM191B
−
|AFAP1 antisense RNA 1
+
|NA
−
|Barrett's esophagus and esophageal adenocarcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''AGAP2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0275096 HSALNT0275096]
−
|[[AGAP2-AS1]]
+
|[[LINC00528]]
−
|"LOC100130776, PUNISHER"
+
|C22orf37,FLJ40542
−
|AGAP2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''Alpha 250/Alpha 280''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287824 HSALNT0287824]
−
|[[NONHSAT104559]],[[lnc-NDST1-1:2]]
+
|[[ASMTL-AS1]]
−
|N/A
+
|CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330
−
|N/A
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ANP32A-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288887 HSALNT0288887]
 
|[[ANP32A-IT1]]
 
|[[ANP32A-IT1]]
−
|"FLJ11722, HsT18971"
+
|C15orf28,NCRNA00321,FLJ11722,HsT18971
−
|ANP32A intronic transcript 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ARRDC1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289396 HSALNT0289396]
−
|[[ARRDC1-AS1]]
+
|[[RUSC1-AS1]]
−
|N/A
+
|C1orf104,FLJ35976
−
|ARRDC1 antisense RNA 1
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ASAP1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0084628 HSALNT0084628]
−
|[[ASAP1-IT1]]
+
|[[LINC01194]]
−
|"HSPC054, NCRNA00050, ASAP1IT, ASAP1-IT"
+
|CT49,TAG
−
|ASAP1 intronic transcript 1
+
|NA
−
|_
+
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 
|-
 
|-
−
|''ASMTL-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289468 HSALNT0289468]
−
|[[ASMTL-AS1]]
+
|[[NONHSAT040032]]
−
|FLJ13330
+
|C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049
−
|ASMTL antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ATP1A1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0121060 HSALNT0121060]
−
|[[ATP1A1-AS1]]
+
|[[NPSR1-AS1]]
−
|MGC16179
+
|AAA1,IMAGE:4827585
−
|ATP1A1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''B3GALT5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0074370 HSALNT0074370]
−
|[[B3GALT5-AS1]]
+
|[[LINC00575]]
−
|N/A
+
|C4orf11
−
|B3GALT5 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''B4GALT1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0137345 HSALNT0137345]
−
|[[B4GALT1-AS1]]
+
|[[LINC01602]]
−
|N/A
+
|T1560
−
|B4GALT1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BAALC-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289433 HSALNT0289433]
−
|[[BAALC-AS2]]
+
|[[FAM13A-AS1]]
−
|MGC39526
+
|FAM13A1OS,FAM13AOS,NCRNA00039
−
|BAALC antisense RNA 2
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BCAR4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289186 HSALNT0289186]
−
|[[BCAR4]]
+
|[[MIRLET7DHG]]
−
|N/A
+
|NA
−
|breast cancer anti-estrogen resistance 4 (non-protein coding)
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BFSP2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0155254 HSALNT0155254]
−
|[[BFSP2-AS1]]
+
|[[MIR181A2HG]]
−
|MGC2848
+
|NA
−
|BFSP2 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BGLT3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289283 HSALNT0289283]
−
|[[BGLT3]]
+
|[[WDFY3-AS2]]
−
|"LINC01083, BGL3, lncRNA-BGL3"
+
|C4orf12,NCRNA00247,FBI4
−
|beta globin locus transcript 3 (non-protein coding)
+
|NA
−
|Bcr-Abl-positive leukemia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BIN3-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0154555 HSALNT0154555]
−
|[[BIN3-IT1]]
+
|[[PAPPA-AS1]]
−
|FLJ14107
+
|PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156
−
|BIN3 intronic transcript 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BIRC6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0136307 HSALNT0136307]
−
|[[BIRC6-AS1]]
+
|[[LINC00293]]
−
|N/A
+
|BEYLA
−
|BIRC6 antisense RNA 1
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BIRC6-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030983 HSALNT0030983]
−
|[[BIRC6-AS2]]
+
|[[SIX3-AS1]]
−
|megamind
+
|SIX3OS
−
|BIRC6 antisense RNA 2
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BISPR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211503 HSALNT0211503]
−
|[[BISPR]]
+
|[[Lnc-C14orf101-5:1]]
−
|N/A
+
|OTX2OS1
−
|BST2 interferon stimulated positive regulator (non-protein coding)
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BOK-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0063422 HSALNT0063422]
−
|[[BOK-AS1]]
+
|[[LINC01192]]
−
|"NCRNA00151, NAToB"
+
|CT64
−
|BOK antisense RNA 1
+
|NA
−
|testicular cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''BRWD1-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217123 HSALNT0217123]
−
|[[BRWD1-AS2]]
+
|[[LINC01193]]
−
|N/A
+
|CT60,LOC348120
−
|BRWD1 antisense RNA 2
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''C1QTNF9B-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289664 HSALNT0289664]
 
|[[C1QTNF9B-AS1]]
 
|[[C1QTNF9B-AS1]]
 
|PCOTH
 
|PCOTH
−
|C1QTNF9B antisense RNA 1
+
|NA
 +
|pathogenic process
 
|prostate cancer
 
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''C21orf91-OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289623 HSALNT0289623]
−
|[[C21orf91-OT1]]
+
|[[ATP6V1G2-DDX39B]]
−
|D21S2089E
+
|NA
−
|C21orf91 overlapping transcript 1
+
|NA
−
|_
+
|pathogenic process
 +
|dilated cardiomyopathy
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''C5orf66-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289498 HSALNT0289498]
−
|[[C5orf66-AS1]]
+
|[[FAM226B]]
−
|"CTC-276P9.1, Epist"
+
|CXorf50B,NCRNA00246B,LINC00246B
−
|C5orf66 antisense RNA 1
+
|NA
−
|esophageal squamous cell carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''C5orf66-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289321 HSALNT0289321]
−
|[[C5orf66-AS2]]
+
|[[LINC00163]]
−
|N/A
+
|C21orf134,NCRNA00163,NLC1-A,NLC1A
−
|C5orf66 antisense RNA 2
+
|NA
−
|_
+
|pathogenic process
 +
|narcolepsy
 +
|Mental Disorders;Nervous System Diseases
 
|-
 
|-
−
|''C8orf34-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289505 HSALNT0289505]
−
|[[C8orf34-AS1]]
+
|[[LINC00165]]
−
|N/A
+
|C21orf135,NCRNA00165,NLC1-B
−
|C8orf34 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CACNA1G-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290297 HSALNT0290297]
−
|[[CACNA1G-AS1]]
+
|[[NONHSAT035776]]
−
|N/A
+
|ENSG00000251002
−
|CACNA1G antisense RNA 1
+
|NA
−
| keloid
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CAPN10-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0274212 HSALNT0274212]
−
|[[CAPN10-AS1]]
+
|[[LINC00322]]
−
|locus959
+
|C21orf136,NCRNA00322,FLJ16545
−
|CAPN10 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CARD8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289741 HSALNT0289741]
−
|[[CARD8-AS1]]
+
|[[NONHSAT102417]]
−
|LOC100505812
+
|DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417
−
|CARD8 antisense RNA 1
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CARMN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289527 HSALNT0289527]
−
|[[CARMN]]
+
|[[NONHSAT128494]]
−
|CARMEN
+
|ncRNA 21A,NONHSAT128494
−
|cardiac mesoderm enhancer-associated non-coding RNA
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC11''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289409 HSALNT0289409]
−
|[[CASC11]]
+
|[[TLX1NB]]
−
|"TCONSN/A00014535, LINC00990, CARLo-7"
+
|TD1,TDI,APT-B7
−
|cancer susceptibility candidate 11 (non-protein coding)
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|leukemogenesis
 +
|Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''CASC15''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289662 HSALNT0289662]
−
|[[CASC15]]
+
|[[C15orf2]]
−
|N/A
+
|NA
−
|cancer susceptibility candidate 15 (non-protein coding)
+
|NA
−
|metastatic melanoma, neuroblastoma
+
|pathogenic process
 +
|Angelman syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''CASC19''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290097 HSALNT0290097]
−
|[[CASC19]]
+
|[[NPAP1]]
−
|CARLo-6
+
|NA
−
|cancer susceptibility candidate 19 (non-protein coding)
+
|NA
−
|prostate cancer
+
|pathogenic process
 +
|Angelman syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''CASC2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0217406 HSALNT0217406]
−
|[[CASC2]]
+
|[[NONHSAT040875]]
−
|N/A
+
|NCRNA00199
−
|cancer susceptibility candidate 2 (non-protein coding)
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|Prader-Willi syndrome
 +
|Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''CASC21''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289227 HSALNT0289227]
−
|[[CASC21]]
+
|[[NONHSAT040920]]
−
|CARLo-2
+
|NCRNA00198
−
|cancer susceptibility candidate 21 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|Prader-Willi syndrome
 +
|Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262816 HSALNT0262816]
 +
|[[MIMT1]]
 +
|MIM1,NCRNA00067,LINC00067
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC22''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289180 HSALNT0289180]
−
|[[CASC22]]
+
|[[MIR34AHG]]
−
|"TCONSN/A00024290, LincRNA-ENST00000515084"
+
|NA
−
|cancer susceptibility candidate 22 (non-protein coding)
+
|NA
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CASC9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289357 HSALNT0289357]
−
|[[CASC9]]
+
|[[LINC02570]]
−
|"LINC00981, ESCCAL-1"
+
|XXbac-BPG27H4.8
−
|cancer susceptibility candidate 9 (non-protein coding)
+
|NA
−
|predicted esophageal squamous cell carcinoma
+
|pathogenic process
 +
|MHC-associated diseases
 +
|Immune System Diseases
 
|-
 
|-
−
|''CBR3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290177 HSALNT0290177]
−
|[[CBR3-AS1]]
+
|[[RNY1]]
−
|PlncRNA-1
+
|NA
−
|CBR3 antisense RNA 1
+
|NA
−
|esophageal squamous carcinoma cell
+
|pathogenic process
 +
|cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer
 +
|Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases
 
|-
 
|-
−
|''CCDC18-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289378 HSALNT0289378]
−
|[[CCDC18-AS1]]
+
|[[NKX2-2-AS1]]
−
|ENST00000440778.1
+
|NKX2-2AS
−
|CCDC18 antisense RNA 1
+
|transcriptional regulation
−
|Adolescent Idiopathic Scoliosis
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CCDC26''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290151 HSALNT0290151]
−
|[[CCDC26]]
+
|[[NONHSAT023851]]
−
|"MGC27434, RAM"
+
|FJ515872.1,NONHSAT023851
−
|CCDC26 long non-coding RNA
+
|transcriptional regulation
−
|glioma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CCEPR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289607 HSALNT0289607]
−
|[[CCEPR]]
+
|[[Anti-NOS2A]]
−
|CCHE1
+
|NA
−
|cervical carcinoma expressed PCNA regulatory lncRNA
+
|NA
−
|cervical cancer
+
|pathogenic process
 +
|meningioma;glioblastoma
 +
|Neoplasms;Nervous System Diseases
 
|-
 
|-
−
|''CDKN1A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289687 HSALNT0289687]
 
|[[CDKN1A-AS1]]
 
|[[CDKN1A-AS1]]
 
|p21NAT
 
|p21NAT
−
|CDKN1A antisense RNA 1
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CDR1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0116668 HSALNT0116668]
−
|[[CDR1-AS]]
+
|[[RPS6KA2-AS1]]
−
|"CDR1NAT, ciRS-7, CDR1as"
+
|NA
−
|CDR1 antisense RNA
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CDRT7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289384 HSALNT0289384]
−
|[[CDRT7]]
+
|[[PAPPA-AS2]]
−
|"NCRNA00025, LINC00025"
+
|AGU1
−
|CMT1A duplicated region transcript 7 (non-protein coding)
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CDRT8''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0262802 HSALNT0262802]
−
|[[CDRT8]]
+
|[[ZIM2-AS1]]
−
|N/A
+
|ZIM2as
−
|CMT1A duplicated region transcript 8
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CECR3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289824 HSALNT0289824]
−
|[[CECR3]]
+
|[[Lnc-DLX5-3:1]]
−
|N/A
+
|Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1
−
|"cat eye syndrome chromosome region, candidate 3 (non-protein coding)"
+
|transcriptional regulation
−
|cat eye syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CECR5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289481 HSALNT0289481]
−
|[[CECR5-AS1]]
+
|[[ADORA2A-AS1]]
−
|NCRNA00017
+
|C22orf45,FLJ34651
−
|CECR5 antisense RNA 1
+
|NA
−
|cat eye syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''CECR7''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290146 HSALNT0290146]
−
|[[CECR7]]
+
|[[POU5F1P4]]
−
|SAHL1
+
|NA
−
|"cat eye syndrome chromosome region, candidate 7 (non-protein coding)"
+
|NA
−
|cat eye syndrome
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''CECR9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290033 HSALNT0290033]
−
|[[CECR9]]
+
|[[LSINCT1]]
−
|N/A
+
|NA
−
|"cat eye syndrome chromosome region, candidate 9 (non-protein coding)"
+
|NA
−
|cat eye syndrome
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CEP83-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290034 HSALNT0290034]
−
|[[CEP83-AS1]]
+
|[[LSINCT10]]
−
|N/A
+
|NA
−
|CEP83 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CIRBP-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290035 HSALNT0290035]
−
|[[CIRBP-AS1]]
+
|[[LSINCT11]]
−
|MGC39338
+
|NA
−
|CIRBP antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CLRN1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290036 HSALNT0290036]
−
|[[CLRN1-AS1]]
+
|[[LSINCT12]]
−
|UCRP
+
|NA
−
|CLRN1 antisense RNA 1
+
|NA
−
|Usher syndrome type 3
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''COPG2IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290037 HSALNT0290037]
−
|[[COPG2IT1]]
+
|[[LSINCT2]]
−
|"CIT1, NCRNA00170, COPG2AS"
+
|NA
−
|COPG2 imprinted transcript 1 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CPS1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290038 HSALNT0290038]
−
|[[CPS1-IT1]]
+
|[[LSINCT3]]
−
|"PRO0132, CPS1-IT"
+
|NA
−
|CPS1 intronic transcript 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CSNK1G2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290039 HSALNT0290039]
−
|[[CSNK1G2-AS1]]
+
|[[LSINCT4]]
−
|MGC39696
+
|NA
−
|CSNK1G2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CSTF3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290041 HSALNT0290041]
−
|[[CSTF3-AS1]]
+
|[[LSINCT6]]
−
|N/A
+
|NA
−
|CSTF3 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CTBP1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290042 HSALNT0290042]
−
|[[CTBP1-AS]]
+
|[[LSINCT7]]
−
|PCAT10
+
|NA
−
|CTBP1 antisense RNA
+
|NA
−
| prostate cancer
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CTBP1-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290043 HSALNT0290043]
−
|[[CTBP1-AS2]]
+
|[[LSINCT8]]
−
|MGC21675
+
|NA
−
|CTBP1 antisense RNA 2 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CYP1B1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290044 HSALNT0290044]
−
|[[CYP1B1-AS1]]
+
|[[LSINCT9]]
−
|MGC34824
+
|NA
−
|CYP1B1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer;breast cancer
 +
|Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''CYP51A1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289676 HSALNT0289676]
−
|[[CYP51A1-AS1]]
+
|[[NONHSAT016928]]
−
|"ENST00000453068, LRRD1-AS1"
+
|FLJ31066,NONHSAT016928,lnc-FANK1-3:1
−
|CYP51A1 antisense RNA 1
+
|transcriptional regulation
−
|renal cell carcinoma
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DACOR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290032 HSALNT0290032]
−
|[[DACOR1]]
+
|[[LRRC3DN]]
−
|TCONSN/A00023265
+
|C21orf30,DKFZP434C128
−
|DNMT1-associated colon cancer repressed lncRNA 1
+
|transcriptional regulation
−
|colon cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DANT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266984 HSALNT0266984]
−
|[[DANT1]]
+
|[[SNHG11]]
−
|N/A
+
|C20orf198,LINC00101,NCRNA00101
−
|"DXZ4 associated non-coding transcript 1, proximal"
+
|NA
−
|_
+
|pathogenic process
 +
|obesity
 +
|Nutritional and Metabolic Diseases
 
|-
 
|-
−
|''DANT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289880 HSALNT0289880]
−
|[[DANT2]]
+
|[[NONHSAT113225]]
−
|N/A
+
|NONHSAT113225,ENSG00000220635
−
|"DXZ4 associated non-coding transcript 2, distal"
+
|ceRNA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DAOA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0006368 HSALNT0006368]
−
|[[DAOA-AS1]]
+
|[[ENST00000444042.2]]
−
|G30
+
|ncRNA-a3
−
|DAOA antisense RNA 1
+
|transcriptional regulation
−
|bipolar illness,schizophrenia
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DAPK1-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027470 HSALNT0027470]
−
|[[DAPK1-IT1]]
+
|[[ENST00000417473.2]]
−
|N/A
+
|ncRNA-a5
−
|DAPK1 intronic transcript 1
+
|transcriptional regulation
−
| pancreatic cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DBH-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289066 HSALNT0289066]
−
|[[DBH-AS1]]
+
|[[ENST00000429328.2]]
−
|BPR
+
|PDZK1IP1-AS1,ncRNA-a4
−
|DBH antisense RNA 1
+
|transcriptional regulation
−
|hepatocellular carcinoma
+
|NA
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289936 HSALNT0289936]
 +
|[[NONHSAT059436]]
 +
|ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436
 +
|NA
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DGCR10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289705 HSALNT0289705]
−
|[[DGCR10]]
+
|[[CHL1-AS2]]
−
|DGS-B
+
|NA
−
|DiGeorge syndrome critical region gene 10 (non-protein coding)
+
|NA
−
|DiGeorge syndrome
+
|pathogenic process
 +
|adolescent idiopathic scoliosis
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''DGCR11''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0076084 HSALNT0076084]
−
|[[DGCR11]]
+
|[[SEC24B-AS1]]
−
|DGS-D
+
|1/2-SBSRNA4
−
|DiGeorge syndrome critical region gene 11 (non-protein coding)
+
|siRNA
−
|DiGeorge and velo-cardio-facial syndrome
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DGCR12''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290137 HSALNT0290137]
−
|[[DGCR12]]
+
|[[PDZRN3-AS1]]
−
|DGS-E
+
|NA
−
|DiGeorge syndrome critical region gene 12 (non-protein coding)
+
|NA
−
|DiGeorge and velo-cardio-facial syndrome
+
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''DGCR5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290237 HSALNT0290237]
−
|[[DGCR5]]
+
|[[SCAANT1]]
−
|"NCRNA00037, LINC00037"
+
|ATXN7-AS1
−
|DiGeorge syndrome critical region gene 5 (non-protein coding)
+
|transcriptional regulation
−
|DiGeorge syndrome
+
|pathogenic process
 +
|spinocerebellar ataxia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''DGCR9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289594 HSALNT0289594]
−
|[[DGCR9]]
+
|[[AK123790]]
−
|"DGS-A, POM121L5P"
+
|NA
−
|DiGeorge syndrome critical region gene 9 (non-protein coding)
+
|NA
−
|DiGeorge syndrome
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DIAPH2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289911 HSALNT0289911]
−
|[[DIAPH2-AS1]]
+
|[[LINC01451]]
−
|N/A
+
|NA
−
|DIAPH2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DISC1FP1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290401 HSALNT0290401]
−
|[[DISC1FP1]]
+
|[[ZNF350-AS1]]
−
|N/A
+
|NA
−
|DISC1 fusion partner 1 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''DLG2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289845 HSALNT0289845]
−
|[[DLG2-AS1]]
+
|[[GADD45G]]
−
|"PSZA11q14, SZ-1"
+
|NA
−
|DLG2 antisense RNA 1
+
|NA
−
|schizophrenia
+
|pathogenic process
 +
|pituitary adenoma
 +
|Endocrine System Diseases;Neoplasms;Nervous System Diseases
 
|-
 
|-
−
|''DLGAP1-AS3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289410 HSALNT0289410]
−
|[[DLGAP1-AS3]]
+
|[[Lnc-RASA1-3:23]]
−
|N/A
+
|AK082072,linc-POLR3G-8,ENSG00000247828
−
|DLGAP1 antisense RNA 3
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DLX6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289736 HSALNT0289736]
−
|[[DLX6-AS1]]
+
|[[DAPK1]]
−
|"FLJ34048, Evf-2"
+
|NA
−
|DLX6 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''DNM3OS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290048 HSALNT0290048]
−
|[[DNM3OS]]
+
|[[MAP3K14]]
−
|"MIR199A2HG, DNM3-AS1"
+
|MAP3K14
−
|DNM3 opposite strand/antisense RNA
+
|NA
−
|Sézary syndrome
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''DRAIC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290150 HSALNT0290150]
−
|[[DRAIC]]
+
|[[PPP3CB]]
−
|N/A
+
|NA
−
|"downregulated RNA in cancer, inhibitor of cell invasion and migration"
+
|NA
−
|prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''DSCR10''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0151531 HSALNT0151531]
−
|[[DSCR10]]
+
|[[DAPK1-IT1]]
−
|N/A
+
|NA
−
|Down syndrome critical region 10 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''DSCR9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288990 HSALNT0288990]
−
|[[DSCR9]]
+
|[[GDNF-AS1]]
−
|NCRNA00038
+
|GDNFOS
−
|Down syndrome critical region 9 (non-protein coding)
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|Alzheimer's disease
 +
|Mental Disorders;Nervous System Diseases
 
|-
 
|-
−
|''DUBR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029702 HSALNT0029702]
−
|[[DUBR]]
+
|[[BIRC6-AS2]]
−
|N/A
+
|megamind
−
|DPPA2 upstream binding RNA
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''EGFR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0029692 HSALNT0029692]
−
|[[EGFR-AS1]]
+
|[[BIRC6-AS1]]
−
|N/A
+
|NA
−
|EGFR antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ELFN1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289310 HSALNT0289310]
−
|[[ELFN1-AS1]]
+
|[[LINC00854]]
−
|N/A
+
|NA
−
|ELFN1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''ENTPD3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290332 HSALNT0290332]
−
|[[ENTPD3-AS1]]
+
|[[Uc.73]]
−
|FLJ36665
+
|NA
−
|ENTPD3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''EPB41L4A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289841 HSALNT0289841]
−
|[[EPB41L4A-AS1]]
+
|[[FR0257520]]
−
|TIGA1
+
|NA
−
|EPB41L4A antisense RNA 1
+
|NA
−
|cancer
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''EPB41L4A-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290104 HSALNT0290104]
−
|[[EPB41L4A-AS2]]
+
|[[NRG1]]
−
|FLJ11235
+
|NA
−
|EPB41L4A antisense RNA 2 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''ERC2-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289689 HSALNT0289689]
−
|[[ERC2-IT1]]
+
|[[CDKN2B-AS11]]
−
|Po42
+
|NA
−
|ERC2 intronic transcript 1
+
|NA
−
|_
+
|pathogenic process;developmental process
 +
|stroke
 +
|Cardiovascular Diseases;Nervous System Diseases
 
|-
 
|-
−
|''ERICH1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289690 HSALNT0289690]
−
|[[ERICH1-AS1]]
+
|[[CDKN2B-AS12]]
−
|N/A
+
|NA
−
|ERICH1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|glioma
 +
|Neoplasms
 
|-
 
|-
−
|''EWSAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289691 HSALNT0289691]
−
|[[EWSAT1]]
+
|[[CDKN2B-AS13]]
−
|FLJ33768
+
|NA
−
|Ewing sarcoma associated transcript 1
+
|NA
−
|Ewing sarcoma
+
|pathogenic process
 +
|plexiform neurofibroma
 +
|Neoplasms;Nervous System Diseases
 
|-
 
|-
−
|''EXOC3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289697 HSALNT0289697]
−
|[[EXOC3-AS1]]
+
|[[CDKN2B-AS7]]
−
|N/A
+
|NA
−
|EXOC3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''EXTL3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289826 HSALNT0289826]
−
|[[EXTL3-AS1]]
+
|[[FADS1]]
−
|N/A
+
|NA
−
|EXTL3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lipid metabolism disorder
 +
|Nutritional and Metabolic Diseases
 
|-
 
|-
−
|''F11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289698 HSALNT0289698]
−
|[[F11-AS1]]
+
|[[CDKN2B-AS8]]
−
|N/A
+
|NA
−
|F11 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 
|-
 
|-
−
|''FAM138A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289696 HSALNT0289696]
−
|[[FAM138A]]
+
|[[CDKN2B-AS6]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member A
+
|NA
−
|_
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''FAM138B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289699 HSALNT0289699]
−
|[[FAM138B]]
+
|[[CDKN2B-AS9]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member B
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''FAM138C''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289688 HSALNT0289688]
−
|[[FAM138C]]
+
|[[CDKN2B-AS10]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member C
+
|NA
−
|_
+
|pathogenic process
 +
|stroke
 +
|Cardiovascular Diseases;Nervous System Diseases
 
|-
 
|-
−
|''FAM138D''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288950 HSALNT0288950]
−
|[[FAM138D]]
+
|[[ENST00000456816]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member D
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''FAM138E''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290021 HSALNT0290021]
−
|[[FAM138E]]
+
|[[LOC389332]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member E
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''FAM138F''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290306 HSALNT0290306]
−
|[[FAM138F]]
+
|[[TMEM72]]
−
|F379
+
|NA
−
|family with sequence similarity 138 member F
+
|NA
−
|_
+
|pathogenic process
 +
|clear cell renal cell cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''FAM13A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289641 HSALNT0289641]
−
|[[FAM13A-AS1]]
+
|[[BC029135]]
−
|NCRNA00039
+
|NA
−
|FAM13A antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|renal clear cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''FAM201A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290374 HSALNT0290374]
−
|[[FAM201A]]
+
|[[X91348]]
−
|N/A
+
|NA
−
|family with sequence similarity 201 member A
+
|NA
−
|_
+
|pathogenic process
 +
|renal clear cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''FAM215A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289694 HSALNT0289694]
−
|[[FAM215A]]
+
|[[CDKN2B-AS4]]
−
|"APR-2, LINC00530"
+
|NA
−
|family with sequence similarity 215 member A (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|cancer
 +
|Neoplasms
 
|-
 
|-
−
|''FAM222A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289692 HSALNT0289692]
−
|[[FAM222A-AS1]]
+
|[[CDKN2B-AS2]]
−
|N/A
+
|NA
−
|FAM222A antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|coronary heart disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''FAM226A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289693 HSALNT0289693]
−
|[[FAM226A]]
+
|[[CDKN2B-AS3]]
−
|MGC34827
+
|NA
−
|family with sequence similarity 226 member A (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|intracranial aneurysm
 +
|Cardiovascular Diseases;Nervous System Diseases
 
|-
 
|-
−
|''FAM226B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289695 HSALNT0289695]
−
|[[FAM226B]]
+
|[[CDKN2B-AS5]]
−
|N/A
+
|NA
−
|family with sequence similarity 226 member B (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''FAM27E3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290319 HSALNT0290319]
−
|[[FAM27E3]]
+
|[[T-UCRs]]
−
|MGC42630
+
|NA
−
|family with sequence similarity 27 member E3
+
|NA
−
|_
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''FAM41AY1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289530 HSALNT0289530]
−
|[[FAM41AY1]]
+
|[[51A]]
−
|N/A
+
|NA
−
|"family with sequence similarity 41 member A, Y-linked 1"
+
|splicing regulation
−
|_
+
|pathogenic process
 +
|Alzheimer's disease
 +
|Mental Disorders;Nervous System Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290163 HSALNT0290163]
 +
|[[RAB4B-EGLN2]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|cancer
 +
|Neoplasms
 
|-
 
|-
−
|''FAM41C''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290167 HSALNT0290167]
−
|[[FAM41C]]
+
|[[RERT]]
−
|N/A
+
|NA
−
|family with sequence similarity 41 member C
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''FAM66C''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0265263 HSALNT0265263]
−
|[[FAM66C]]
+
|[[LINC00237]]
−
|N/A
+
|NCRNA00237
−
|family with sequence similarity 66 member C
+
|NA
−
|_
+
|pathogenic process
 +
|macrocephaly;obesity
 +
|Musculoskeletal Diseases;Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena
 
|-
 
|-
−
|''FAM74A3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267186 HSALNT0267186]
−
|[[FAM74A3]]
+
|[[LINC01370]]
−
|OTTHUMG00000067149
+
|HI-LNC25,HILNC25
−
|family with sequence similarity 74 member A3
+
|NA
−
|_
+
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''FAM83H-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289114 HSALNT0289114]
−
|[[FAM83H-AS1]]
+
|[[LINC01574]]
−
|onco-lncRNA-3
+
|HI-LNC12,TCONS_00009551
−
|FAM83H antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|type 2 diabetes
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''FAM87A''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290159 HSALNT0290159]
−
|[[FAM87A]]
+
|[[PTHLH]]
−
|N/A
+
|NA
−
|family with sequence similarity 87 member A
+
|NA
−
|_
+
|pathogenic process
 +
|brachydactyly
 +
|Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''FAS-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189394 HSALNT0189394]
−
|[[FAS-AS1]]
+
|[[NONHSAT028496]]
−
|SAF
+
|CISTR-ACT,CISTRACT,re52431
−
|FAS antisense RNA 1
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|brachydactyly
 +
|Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities
 
|-
 
|-
−
|''FGF10-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289862 HSALNT0289862]
−
|[[FGF10-AS1]]
+
|[[HELLPAR]]
−
|RP11-473L15.2
+
|LINC-HELLP
−
|FGF10 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|HELLP syndrome
 +
|Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''FLG-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289904 HSALNT0289904]
−
|[[FLG-AS1]]
+
|[[LINC01125]]
−
|N/A
+
|NA
−
|FLG antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|uremia
 +
|Male Urogenital Diseases
 
|-
 
|-
−
|''FLVCR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289544 HSALNT0289544]
−
|[[FLVCR1-AS1]]
+
|[[AC002511.1]]
−
|LQK1
+
|LINC01531
−
|FLVCR1 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''FMR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289609 HSALNT0289609]
−
|[[FMR1-AS1]]
+
|[[AP000688.29]]
−
|"ASFMR1, FMR4"
+
|AP000688.2
−
|FMR1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''FOXC2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289832 HSALNT0289832]
−
|[[FOXC2-AS1]]
+
|[[FFAR2]]
−
|ODRUL
+
|NA
−
|FOXC2 antisense RNA 1
+
|NA
−
|osteosarcoma
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''FOXG1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290222 HSALNT0290222]
−
|[[FOXG1-AS1]]
+
|[[RP4-620F22.3]]
−
|FOXG1-AS
+
|AC099063.2
−
|FOXG1 antisense RNA 1 (head to head)
+
|NA
−
|autism spectrum disorders
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''FRGCA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290227 HSALNT0290227]
−
|[[FRGCA]]
+
|[[RP5-843L14.1]]
−
|LncRNA-AP001631.9
+
|LINC01716
−
|"FOXM1-regulated, gastric cancer associated"
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|enterovirus 71 infection
 +
|Virus Diseases
 
|-
 
|-
−
|''GABPB1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287285 HSALNT0287285]
−
|[[GABPB1-AS1]]
+
|[[MAGEA8-AS1]]
−
|N/A
+
|RP5-869M20.2
−
|GABPB1 antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GACAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289019 HSALNT0289019]
−
|[[ENST00000441383.1]]
+
|[[LHX5-AS1]]
−
|"LINC00876, AC096655.1-002"
+
|locus4010
−
|gastric cancer associated transcript 1 (non-protein coding)
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GACAT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288902 HSALNT0288902]
−
|[[ENST00000579368.1]]
+
|[[CAPN10-AS1]]
−
|HMlincRNA717
+
|CAPN10-DT,locus959
−
|gastric cancer associated transcript 2 (non-protein coding)
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GACAT3''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289404 HSALNT0289404]
−
|[[ENST00000426539.1]]
+
|[[STAM-AS1]]
−
|lncRNA-AC130710
+
|locus3182
−
|gastric cancer associated transcript 3 (non-protein coding)
+
|NA
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GAPLINC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0148276 HSALNT0148276]
−
|[[GAPLINC]]
+
|[[PTENP1-AS]]
−
|TCONSN/A00026238
+
|PTENpg1-asRNA
−
|"gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA"
+
|transcriptional regulation
−
|gastric cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''GAS1RR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289562 HSALNT0289562]
−
|[[GAS1RR]]
+
|[[AF116616]]
−
|LncRNA-Hh
+
|NA
−
|GAS1 adjacent regulatory RNA
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GAS6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289589 HSALNT0289589]
−
|[[GAS6-AS1]]
+
|[[AK094838]]
−
|N/A
+
|NA
−
|GAS6 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GAS8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289620 HSALNT0289620]
−
|[[GAS8-AS1]]
+
|[[ASLNC00339]]
−
|N/A
+
|NA
−
|GAS8 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GATA3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289629 HSALNT0289629]
−
|[[GATA3-AS1]]
+
|[[BC002350]]
−
|N/A
+
|NA
−
|GATA3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GATA6-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289651 HSALNT0289651]
−
|[[GATA6-AS1]]
+
|[[BC091525]]
−
|locus5689
+
|NA
−
|GATA6 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GDNF-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289652 HSALNT0289652]
−
|[[GDNF-AS1]]
+
|[[BE503655]]
−
|GDNFOS
+
|NA
−
|GDNF antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GLIDR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289753 HSALNT0289753]
−
|[[GLIDR]]
+
|[[ENO1]]
−
|"MGC21881, TCONSN/A00015562"
+
|NA
−
|glioblastoma down-regulated RNA
+
|NA
−
| glioblastoma
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GLIS3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289835 HSALNT0289835]
−
|[[GLIS3-AS1]]
+
|[[FKBP10]]
−
|MGC16153
+
|NA
−
|GLIS3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GNG12-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290064 HSALNT0290064]
−
|[[GNG12-AS1]]
+
|[[MYHAS]]
−
|N/A
+
|NA
−
|GNG12 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|osteosarcoma
 +
|Neoplasms
 
|-
 
|-
−
|''GTSCR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289985 HSALNT0289985]
−
|[[GTSCR1]]
+
|[[LncRNA-LALR1]]
−
|N/A
+
|NA
−
|"Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding)"
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|liver cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''H1FX-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0091577 HSALNT0091577]
−
|[[H1FX-AS1]]
+
|[[NR2F1-AS1]]
−
|FLJ34151
+
|FLJ42709
−
|H1FX antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HAND2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289709 HSALNT0289709]
−
|[[HAND2-AS1]]
+
|[[CK19]]
−
|"DEIN, NBLA00301, FLJ11539"
+
|NA
−
|HAND2 antisense RNA 1 (head to head)
+
|NA
−
|neuroblastoma
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''HAS2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289943 HSALNT0289943]
−
|[[HAS2-AS1]]
+
|[[Llme23]]
−
|"HASNT, NCRNA00077"
+
|NA
−
|HAS2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|melanoma
 +
|Neoplasms
 
|-
 
|-
−
|''HCCAT5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289553 HSALNT0289553]
−
|[[HCCAT5]]
+
|[[AC096655.1]]
−
|"HTA, FJ222407"
+
|NA
−
|hepatocellular carcinoma associated transcript 5 (non-protein coding)
+
|NA
−
| hepatocellular carcinoma
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''HCG27''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289178 HSALNT0289178]
−
|[[HCG27]]
+
|[[ENST00000602507.1]]
−
|"bPG299F13.9, bCX101P6.9, bQB115I13.2, FLJ40123"
+
|Lnc-Ang362
−
|HLA complex group 27 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|Ang II-associated cardiovascular disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''HCG4''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289261 HSALNT0289261]
−
|[[HCG4]]
+
|[[STX18-AS1]]
−
|"HCGIV-10, HCGIV.9"
+
|LOC100507266
−
|HLA complex group 4 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|atrial septal defect
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''HCG4B''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289849 HSALNT0289849]
−
|[[HCG4B]]
+
|[[GHSR]]
−
|"HCGIV-6, HCGIV.5, HCGIV-06, bCX67J3.3, Em:AB023056.16, bPG309N1.1, bQB90C11.3"
+
|NA
−
|HLA complex group 4B (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HCG9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289210 HSALNT0289210]
−
|[[HCG9]]
+
|[[ENST00000452148.2]]
−
|"PERB11, HCGIX, HCGIX4, HCGIX-4"
+
|PCAN-R2
−
|HLA complex group 9 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''HCP5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289702 HSALNT0289702]
−
|[[HCP5]]
+
|[[CES1P1]]
−
|"D6S2650E, P5-1"
+
|NA
−
|HLA complex P5 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HELLPAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289892 HSALNT0289892]
−
|[[HELLPAR]]
+
|[[LINC00210]]
−
|LINC-HELLP
+
|NA
−
|HELLP associated long non-coding RNA
+
|NA
−
|extravillous trophoblast
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HEXA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290006 HSALNT0290006]
−
|[[HEXA-AS1]]
+
|[[LOC100506974]]
−
|FLJ13315
+
|NA
−
|HEXA antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HIF1A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290219 HSALNT0290219]
−
|[[HIF1A-AS1]]
+
|[[RP3-508I15.14]]
−
|5'aHIF-1A
+
|NA
−
|HIF1A antisense RNA 1
+
|NA
−
|kidney cancer
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HIF1A-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290243 HSALNT0290243]
−
|[[HIF1A-AS2]]
+
|[[SLC6A6]]
−
|"3'aHIF-1A, aHIF"
+
|NA
−
|HIF1A antisense RNA 2
+
|NA
−
| kidney cancer
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HNF1A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290342 HSALNT0290342]
−
|[[HNF1A-AS1]]
+
|[[Uc003bgl.1]]
−
|FLJ38690
+
|NA
−
|HNF1A antisense RNA 1
+
|NA
−
|adenocarcinoma, oesophageal adenocarcinoma
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HNF4A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289075 HSALNT0289075]
−
|[[HNF4A-AS1]]
+
|[[LINC00970]]
−
|uc002xlx
+
|NA
−
|HNF4A antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''HORMAD2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0211868 HSALNT0211868]
−
|[[HORMAD2-AS1]]
+
|[[SALRNA1]]
−
|"MTMR3-AS1, NONHSAG033653"
+
|SAL-RNA1,XLOC_023166
−
|HORMAD2 antisense RNA 1
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HPVC1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222267 HSALNT0222267]
−
|[[HPVC1]]
+
|[[SALRNA3]]
−
|"PE5L, HPV18E5L"
+
|SAL-RNA3,XLOC_025918
−
|human papillomavirus (type 18) E5 central sequence-like 1
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HTT-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0222274 HSALNT0222274]
−
|[[HTT-AS]]
+
|[[SALRNA2]]
−
|HTTAS
+
|SAL-RNA2,XLOC_025931
−
|HTT antisense RNA (head to head)
+
|NA
−
|Huntington's disease
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''HYMAI''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289428 HSALNT0289428]
−
|[[HYMAI]]
+
|[[NONHSAT076558]]
−
|NCRNA00020
+
|GPR1-AS1,GPR1AS
−
|hydatidiform mole associated and imprinted (non-protein coding)
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''IDI2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0226207 HSALNT0226207]
−
|[[IDI2-AS1]]
+
|[[LINC00235]]
−
|"HT009, Em:AC022536.4"
+
|NA
−
|IDI2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|anorexia nervosa
 +
|Mental Disorders
 
|-
 
|-
−
|''IGF2-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289526 HSALNT0289526]
−
|[[IGF2-AS]]
+
|[[1B FGF-antisense transcripts]]
−
|"PEG8, IGF2-AS1"
+
|NA
−
|IGF2 antisense RNA
+
|NA
−
|hepatocelluar carcinoma,prostate cancer, type 1 diabetes, Wilms' tumor
+
|pathogenic process
 +
|endometriosis
 +
|Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''ILF3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290171 HSALNT0290171]
−
|[[ILF3-AS1]]
+
|[[RNA polymerase III-dependent lncRNAs]]
−
|N/A
+
|NA
−
|ILF3 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|diffuse cerebral hypomyelination
 +
|NA
 
|-
 
|-
−
|''INE1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290168 HSALNT0290168]
−
|[[INE1]]
+
|[[REST/CoREST-regulated lncRNAs]]
−
|NCRNA00010
+
|NA
−
|inactivation escape 1 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|Huntington disease
 +
|Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''INE2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289606 HSALNT0289606]
−
|[[INE2]]
+
|[[Alu lncRNAs]]
−
|NCRNA00011
+
|NA
−
|inactivation escape 2 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|macular degeneration
 +
|Eye Diseases
 
|-
 
|-
−
|''IRAIN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290358 HSALNT0290358]
−
|[[IRAIN]]
+
|[[UCH1LAS]]
−
|IGF1R-AS
+
|NA
−
|IGF1R antisense imprinted non-protein coding RNA
+
|NA
−
|_
+
|pathogenic process
 +
|Parkinson's disease
 +
|Nervous System Diseases
 
|-
 
|-
−
|''JMJD1C-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290244 HSALNT0290244]
−
|[[JMJD1C-AS1]]
+
|[[SLC7A2-IT1A/B]]
−
|N/A
+
|NA
−
|JMJD1C antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|progressive encephalopathy with severe infantile anorexia
 +
|Nervous System Diseases
 
|-
 
|-
−
|''KCNK15-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289877 HSALNT0289877]
−
|[[KCNK15-AS1]]
+
|[[Kcna2-AS]]
−
|RP11-445H22.4
+
|NA
−
|KCNK15 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|neuropathic pain
 +
|Nervous System Diseases
 
|-
 
|-
−
|''KCNMB2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289191 HSALNT0289191]
−
|[[KCNMB2-AS1]]
+
|[[NCOA7-AS1]]
−
|RP11-385J1.2
+
|NA
−
|KCNMB2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KCNQ1DN''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290020 HSALNT0290020]
−
|[[KCNQ1DN]]
+
|[[LOC389023]]
−
|"BWRT, HSA404617"
+
|NA
−
|KCNQ1 downstream neighbor (non-protein coding)
+
|transcriptional regulation
−
|Wilms' tumor
+
|pathogenic process
 +
|psychiatric disease
 +
|Nervous System Diseases
 
|-
 
|-
−
|''KIAA1614-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0175124 HSALNT0175124]
−
|[[KIAA1614-AS1]]
+
|[[PTPRJ-AS1]]
−
|RP11-46A10.4
+
|NA
−
|KIAA1614 antisense RNA 1
+
|transcriptional regulation
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''KIF25-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289654 HSALNT0289654]
−
|[[KIF25-AS1]]
+
|[[BM742401]]
−
|HGC6.1.1
+
|NA
−
|KIF25 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LAMP5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289331 HSALNT0289331]
−
|[[LAMP5-AS1]]
+
|[[LINC00951]]
−
|N/A
+
|lincRNA-uc003opf.1,FLJ41649
−
|LAMP5 antisense RNA 1
+
|NA
−
|leukemogenesis
+
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LBX2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290130 HSALNT0290130]
−
|[[LBX2-AS1]]
+
|[[PAWR]]
−
|N/A
+
|NA
−
|LBX2 antisense RNA 1
+
|NA
−
|renal cell carcinoma
+
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''LCAL1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290264 HSALNT0290264]
−
|[[LCAL1]]
+
|[[T-ALL-R-LncR1]]
−
|onco-lncRNA-27
+
|NA
−
|lung cancer associated lncRNA 1
+
|NA
−
| lung cancer
+
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''LHX5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289599 HSALNT0289599]
−
|[[LHX5-AS1]]
+
|[[AK130977]]
−
|locus4010
+
|NA
−
|LHX5 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|malignant pleural mesothelioma
 +
|Neoplasms
 
|-
 
|-
−
|''LIFR-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289625 HSALNT0289625]
−
|[[LIFR-AS1]]
+
|[[AX746718]]
−
|N/A
+
|NA
−
|LIFR antisense RNA 1
+
|NA
−
|preterm birth
+
|pathogenic process
 +
|malignant pleural mesothelioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00029''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289738 HSALNT0289738]
−
|[[LINC00029]]
+
|[[DDR2]]
−
|bA305P22.4
+
|NA
−
|long intergenic non-protein coding RNA 29
+
|NA
−
|_
+
|pathogenic process
 +
|malignant pleural mesothelioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00052''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290003 HSALNT0290003]
−
|[[LINC00052]]
+
|[[LOC100131831]]
−
|FLJ31461
+
|NA
−
|long intergenic non-protein coding RNA 52
+
|NA
−
|_
+
|pathogenic process
 +
|malignant pleural mesothelioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00094''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290144 HSALNT0290144]
−
|[[LINC00094]]
+
|[[POT1-AS1]]
−
|"FLJ35348, bA374P20.3"
+
|NA
−
|long intergenic non-protein coding RNA 94
+
|NA
−
|_
+
|pathogenic process
 +
|malignant pleural mesothelioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00114''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290253 HSALNT0290253]
−
|[[LINC00114]]
+
|[[SNORA17B]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 114
+
|NA
−
|_
+
|pathogenic process
 +
|malignant pleural mesothelioma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00115''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0207421 HSALNT0207421]
−
|[[LINC00115]]
+
|[[GAS6-AS1]]
−
|FLJ22639
+
|NA
−
|long intergenic non-protein coding RNA 115
+
|NA
−
|
+
|pathogenic process
 +
|non-small cell lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00152''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289838 HSALNT0289838]
−
|[[LINC00152]]
+
|[[FMR5]]
−
|MGC4677
+
|NA
−
|long intergenic non-protein coding RNA 152
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|fragile X syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC00160''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0208907 HSALNT0208907]
−
|[[LINC00160]]
+
|[[FOXG1-AS1]]
−
|N/A
+
|FOXG1-AS
−
|long intergenic non-protein coding RNA 160
+
|NA
−
|Breast Cancer
+
|pathogenic process
 +
|autism spectrum disorder
 +
|Mental Disorders
 
|-
 
|-
−
|''LINC00161''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290263 HSALNT0290263]
−
|[[LINC00161]]
+
|[[SYNGAP1-AS1]]
−
|N/A
+
|SYNGAP1-AS
−
|long intergenic non-protein coding RNA 161
+
|NA
−
|_
+
|pathogenic process
 +
|autism spectrum disorder
 +
|Mental Disorders
 
|-
 
|-
−
|''LINC00165''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290176 HSALNT0290176]
−
|[[LINC00165]]
+
|[[RNase MRP]]
−
|NLC1-B
+
|NA
−
|long intergenic non-protein coding RNA 165
+
|NA
−
| narcolepsy
+
|pathogenic process
 +
|cartilage hair hypoplaisia
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00189''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289469 HSALNT0289469]
−
|[[LINC00189]]
+
|[[GABPB1-AS1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 189
+
|NA
−
|Breast Cancer
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00205''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289009 HSALNT0289009]
−
|[[LINC00205]]
+
|[[IDI2-AS1]]
−
|N/A
+
|C10orf110,IDI2-A,HT009,Em:AC022536.4
−
|long intergenic non-protein coding RNA 205
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00235''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289093 HSALNT0289093]
−
|[[LINC00235]]
+
|[[LINC01184]]
−
|N/A
+
|FLJ33630
−
|long intergenic non-protein coding RNA 235
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00237''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290108 HSALNT0290108]
−
|[[LINC00237]]
+
|[[OGT]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 237
+
|NA
−
|macrosomia, obesity, macrocephaly, and ocular abnormalities
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00244''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290077 HSALNT0290077]
−
|[[LINC00244]]
+
|[[NcNRFR]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 244
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00261''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290337 HSALNT0290337]
−
|[[LINC00261]]
+
|[[Uc001lsz]]
−
|"bA216C10.1, HCCDR1, TCONSN/A00027846, ALIEN, DEANR1, onco-lncRNA-17"
+
|NA
−
|long intergenic non-protein coding RNA 261
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|gastric cancer;prostate cancer;liver cancer;lung cancer
 +
|Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00265''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289087 HSALNT0289087]
−
|[[LINC00265]]
+
|[[LINC01090]]
−
|NCRNA00265-1
+
|NA
−
|long intergenic non-protein coding RNA 265
+
|NA
−
|_
+
|pathogenic process
 +
|post-traumatic stress disorder
 +
|Mental Disorders
 
|-
 
|-
−
|''LINC00272''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289981 HSALNT0289981]
−
|[[LINC00272]]
+
|[[LncRNA-DQ786227]]
−
|RP1-223H12.3
+
|NA
−
|long intergenic non-protein coding RNA 272
+
|NA
−
| prostate cancer region
+
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00293''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289876 HSALNT0289876]
−
|[[LINC00293]]
+
|[[JADRR]]
−
|BEYLA
+
|LINC00915,lncRNA-JADE
−
|long intergenic non-protein coding RNA 293
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00294''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290254 HSALNT0290254]
−
|[[LINC00294]]
+
|[[SOX2OT-S1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 294
+
|NA
−
|_
+
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00299''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289870 HSALNT0289870]
−
|[[LINC00299]]
+
|[[HOXA13]]
−
|FLJ45673
+
|NA
−
|long intergenic non-protein coding RNA 299
+
|NA
−
|Intellectual and developmental disability
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00301''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0078946 HSALNT0078946]
−
|[[LINC00301]]
+
|[[SMAD1-AS1]]
−
|MGC39681
+
|ENST00000513542
−
|long intergenic non-protein coding RNA 301
+
|NA
−
|_
+
|pathogenic process
 +
|ventricular septal defects
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00302''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0087329 HSALNT0087329]
−
|[[LINC00302]]
+
|[[FGF10-AS1]]
−
|XP33
+
|RP11-473L15.2
−
|long intergenic non-protein coding RNA 302
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|ventricular septal defects
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00305''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290318 HSALNT0290318]
−
|[[LINC00305]]
+
|[[TUC339]]
−
|"MGC39571, HsT1235"
+
|NA
−
|long intergenic non-protein coding RNA 305
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00307''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289819 HSALNT0289819]
−
|[[LINC00307]]
+
|[[Lnc-CHRAC1-2:1]]
−
|D21S2091E
+
|LINC01130,TCONS_00014875,ERIC
−
|long intergenic non-protein coding RNA 307
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|retinoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00308''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289615 HSALNT0289615]
−
|[[LINC00308]]
+
|[[ARA]]
−
|PRED16
+
|NA
−
|long intergenic non-protein coding RNA 308
+
|NA
−
|_
+
|pathogenic process
 +
|cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00310''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289822 HSALNT0289822]
−
|[[LINC00310]]
+
|[[ESCCAL-5]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 310
+
|NA
−
|_
+
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00311''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290074 HSALNT0290074]
−
|[[LINC00311]]
+
|[[NcC11orf49]]
−
|MGC22001
+
|NA
−
|long intergenic non-protein coding RNA 311
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00313''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290076 HSALNT0290076]
−
|[[LINC00313]]
+
|[[NcHDAC5]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 313
+
|NA
−
|lung cancer
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00314''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290078 HSALNT0290078]
−
|[[LINC00314]]
+
|[[NcRAB31]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 314
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00315''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290080 HSALNT0290080]
−
|[[LINC00315]]
+
|[[NcSRPK1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 315
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00320''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018253 HSALNT0018253]
−
|[[LINC00320]]
+
|[[ENST00000442621.1]]
−
|"PRED14, FLJ37539"
+
|LINC01131,OVAL
−
|long intergenic non-protein coding RNA 320
+
|NA
−
|_
+
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC00322''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289884 HSALNT0289884]
−
|[[LINC00322]]
+
|[[LALR]]
−
|FLJ16545
+
|NA
−
|long intergenic non-protein coding RNA 322
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC00323''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289701 HSALNT0289701]
−
|[[LINC00323]]
+
|[[CEACAMP8]]
−
|"PRED42, FLJ37173"
+
|CEACAMP8
−
|long intergenic non-protein coding RNA 323
+
|NA
−
|_
+
|pathogenic process
 +
|pre-eclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''LINC00324''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290018 HSALNT0290018]
−
|[[LINC00324]]
+
|[[LOC284100]]
−
|"FLJ34790, MGC104931"
+
|NA
−
|long intergenic non-protein coding RNA 324
+
|NA
−
|_
+
|pathogenic process
 +
|pre-eclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''LINC00334''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290023 HSALNT0290023]
−
|[[LINC00334]]
+
|[[LOC391533]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 334
+
|NA
−
|_
+
|pathogenic process
 +
|pre-eclampsia
 +
|Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''LINC00337''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0189558 HSALNT0189558]
−
|[[LINC00337]]
+
|[[LINC01154]]
−
|MGC40168
+
|NA
−
|long intergenic non-protein coding RNA 337
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00339''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0196616 HSALNT0196616]
−
|[[LINC00339]]
+
|[[Lnc-DHX37-1:1]]
−
|HSPC157
+
|BRI3BP-AS1,BRI3BPAS1,Linc1992,TCONS_00020260
−
|long intergenic non-protein coding RNA 339
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|Kawasaki disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00342''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289235 HSALNT0289235]
−
|[[LINC00342]]
+
|[[RNF219-AS1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 342
+
|NA
−
|Non-small cell lung cancer
+
|pathogenic process
 +
|blood pressure
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00346''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289561 HSALNT0289561]
−
|[[LINC00346]]
+
|[[AF086415]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 346
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00347''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289583 HSALNT0289583]
−
|[[LINC00347]]
+
|[[AK056098]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 347
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00426''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289590 HSALNT0289590]
−
|[[LINC00426]]
+
|[[AK095147]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 426
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00441''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289600 HSALNT0289600]
−
|[[LINC00441]]
+
|[[AK294004]]
−
|ncRNA-RB1
+
|NA
−
|long intergenic non-protein coding RNA 441
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00461''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289612 HSALNT0289612]
−
|[[LINC00461]]
+
|[[AP5M1]]
−
|"EyeLinc1, Visc-1a, Visc-1b, Visc-2, LOC645323"
+
|NA
−
|long intergenic non-protein coding RNA 461
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00466''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290110 HSALNT0290110]
−
|[[LINC00466]]
+
|[[ORAOV1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 466
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00467''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290210 HSALNT0290210]
−
|[[LINC00467]]
+
|[[RP1-179N16.3]]
−
|MGC14801
+
|Z95152.1
−
|long intergenic non-protein coding RNA 467
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC00470''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0037026 HSALNT0037026]
−
|[[LINC00470]]
+
|[[LINC01159]]
−
|N/A
+
|linc-Brn1b
−
|long intergenic non-protein coding RNA 470
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289014 HSALNT0289014]
 +
|[[ENST00000604849.1]]
 +
|KDM5C adjacent non-coding transcript
 +
|NA
 +
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00471''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289905 HSALNT0289905]
−
|[[LINC00471]]
+
|[[LINC01157]]
−
|MGC43122
+
|TCONS_00010378,linc-Enc1
−
|long intergenic non-protein coding RNA 471
+
|NA
−
|_
+
|developmental process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00472''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289460 HSALNT0289460]
−
|[[LINC00472]]
+
|[[ENST00000444200.1]]
−
|"dJ288M22.3, FLJ13189"
+
|NA
−
|long intergenic non-protein coding RNA 472
+
|transcriptional regulation
−
|breast cancer
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00473''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290400 HSALNT0290400]
−
|[[LINC00473]]
+
|[[ZNF300P1]]
−
|bA142J11.1
+
|ZNF300P1
−
|long intergenic non-protein coding RNA 473
+
|NA
−
|lung cancer
+
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC00477''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289750 HSALNT0289750]
−
|[[LINC00477]]
+
|[[EEF1A1P9]]
−
|"FLJ32894, FAM191B"
+
|NA
−
|long intergenic non-protein coding RNA 477
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00491''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289796 HSALNT0289796]
−
|[[LINC00491]]
+
|[[ENST00000318333]]
−
|BC008363
+
|NA
−
|long intergenic non-protein coding RNA 491
+
|NA
−
|pancreatic ductal adenocarcinoma
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00493''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289797 HSALNT0289797]
−
|[[LINC00493]]
+
|[[ENST00000374520]]
−
|LOC388789
+
|NA
−
|long intergenic non-protein coding RNA 493
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00494''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289800 HSALNT0289800]
−
|[[LINC00494]]
+
|[[ENST00000422362]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 494
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00507''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289808 HSALNT0289808]
−
|[[LINC00507]]
+
|[[ENST00000455912]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 507
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00511''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289809 HSALNT0289809]
−
|[[LINC00511]]
+
|[[ENST00000456007]]
−
|onco-lncRNA-12
+
|NA
−
|long intergenic non-protein coding RNA 511
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00518''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289810 HSALNT0289810]
−
|[[LINC00518]]
+
|[[ENST00000456185]]
−
|MGC40222
+
|NA
−
|long intergenic non-protein coding RNA 518
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00526''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289817 HSALNT0289817]
−
|[[LINC00526]]
+
|[[EPOR]]
−
|"MGC17515, HsT959"
+
|NA
−
|long intergenic non-protein coding RNA 526
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00528''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289913 HSALNT0289913]
−
|[[LINC00528]]
+
|[[LINC01550]]
−
|FLJ40542
+
|NA
−
|long intergenic non-protein coding RNA 528
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00529''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290142 HSALNT0290142]
−
|[[LINC00529]]
+
|[[PMS2P5]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 529
+
|NA
−
| keratolytic winter erythema
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00536''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290269 HSALNT0290269]
−
|[[LINC00536]]
+
|[[TCF7]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 536
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00538''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290345 HSALNT0290345]
−
|[[LINC00538]]
+
|[[Uc003jfz.2]]
−
|"Yiya, PROX1UT"
+
|NA
−
|long intergenic non-protein coding RNA 538
+
|NA
−
|cancers
+
|pathogenic process
 +
|gastric cardia adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00575''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289095 HSALNT0289095]
−
|[[LINC00575]]
+
|[[ENST00000412690.1]]
−
|N/A
+
|VIN,lnc-ACTR3
−
|long intergenic non-protein coding RNA 575
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|influenza A virus
 +
|Virus Diseases
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288976 HSALNT0288976]
 +
|[[ENST00000427391.1]]
 +
|LINC01200
 +
|transcriptional regulation
 +
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00588''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289097 HSALNT0289097]
−
|[[LINC00588]]
+
|[[LINC01202]]
−
|DKFZP434F122
+
|NA
−
|long intergenic non-protein coding RNA 588
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00593''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290271 HSALNT0290271]
−
|[[LINC00593]]
+
|[[TCONS_00014512]]
−
|MGC42951
+
|NA
−
|long intergenic non-protein coding RNA 593
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00598''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290272 HSALNT0290272]
−
|[[LINC00598]]
+
|[[TCONS_00014978]]
−
|TTL
+
|NA
−
|long intergenic non-protein coding RNA 598
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00608''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290274 HSALNT0290274]
−
|[[LINC00608]]
+
|[[TCONS_00024647]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 608
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00612''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290279 HSALNT0290279]
−
|[[LINC00612]]
+
|[[TCONS_00090092_MEG3]]
−
|"MGC40170, FLJ41814"
+
|NA
−
|long intergenic non-protein coding RNA 612
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00620''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290280 HSALNT0290280]
−
|[[LINC00620]]
+
|[[TCONS_l2_00000179]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 620
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00623''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290283 HSALNT0290283]
−
|[[LINC00623]]
+
|[[TCONS_l2_00004424]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 623
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00628''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290284 HSALNT0290284]
−
|[[LINC00628]]
+
|[[TCONS_l2_00006843]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 628
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00632''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290289 HSALNT0290289]
−
|[[LINC00632]]
+
|[[TCONS_l2_00014091]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 632
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00634''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290291 HSALNT0290291]
−
|[[LINC00634]]
+
|[[TCONS_l2_00018070]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 634
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00635''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290292 HSALNT0290292]
−
|[[LINC00635]]
+
|[[TCONS_l2_00020565]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 635
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00636''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290293 HSALNT0290293]
−
|[[LINC00636]]
+
|[[TCONS_l2_00021262]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 636
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00638''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290296 HSALNT0290296]
−
|[[LINC00638]]
+
|[[TCONS_l2_00030560]]
−
|MGC23270
+
|NA
−
|long intergenic non-protein coding RNA 638
+
|NA
−
|_
+
|pathogenic process
 +
|hepatoblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00649''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289927 HSALNT0289927]
−
|[[LINC00649]]
+
|[[LincRNA1611]]
−
|TCONSN/A00028768
+
|NA
−
|long intergenic non-protein coding RNA 649
+
|NA
−
|_
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00652''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290149 HSALNT0290149]
−
|[[LINC00652]]
+
|[[Ppp3ca]]
−
|HSPC072
+
|NA
−
|long intergenic non-protein coding RNA 652
+
|NA
−
|_
+
|pathogenic process
 +
|Pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00661''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290265 HSALNT0290265]
−
|[[LINC00661]]
+
|[[TC0100223]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 661
+
|NA
−
|_
+
|pathogenic process
 +
|epithelial ovarian cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00662''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290267 HSALNT0290267]
−
|[[LINC00662]]
+
|[[TC0101686]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 662
+
|NA
−
|_
+
|pathogenic process
 +
|epithelial ovarian cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00663''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290268 HSALNT0290268]
−
|[[LINC00663]]
+
|[[TC1500845]]
−
|MGC39821
+
|NA
−
|long intergenic non-protein coding RNA 663
+
|NA
−
|_
+
|pathogenic process
 +
|ovarian cancer
 +
|Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC00667''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289318 HSALNT0289318]
−
|[[LINC00667]]
+
|[[LAMP5-AS1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 667
+
|NA
−
|_
+
|pathogenic process
 +
|acute lymphoblastic leukemia
 +
|Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''LINC00668''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234022 HSALNT0234022]
−
|[[LINC00668]]
+
|[[LINC01228]]
−
|N/A
+
|lincRNA-DYNLRB2-2
−
|long intergenic non-protein coding RNA 668
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00673''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162654 HSALNT0162654]
−
|[[LINC00673]]
+
|[[SGMS1-AS1]]
−
|HI-LNC75
+
|NA
−
|long intergenic non-protein coding RNA 673
+
|NA
−
|type 2 diabetes
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00675''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289206 HSALNT0289206]
−
|[[LINC00675]]
+
|[[PCAT19]]
−
|N/A
+
|LOC100505495,LINC01190
−
|long intergenic non-protein coding RNA 675
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00682''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289521 HSALNT0289521]
−
|[[LINC00682]]
+
|[[ABHD15-AS1]]
−
|N/A
+
|linc-TP53I13,lnc-TP53I13
−
|long intergenic non-protein coding RNA 682
+
|NA
−
|_
+
|pathogenic process
 +
|cardiometabolic disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00685''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289100 HSALNT0289100]
−
|[[LINC00685]]
+
|[[LINC01230]]
−
|OTTHUMT00000055574
+
|linc-DMRT2,lnc-DRMT2,TCONS_00015639
−
|long intergenic non-protein coding RNA 685
+
|NA
−
|_
+
|pathogenic process
 +
|cardiometabolic disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00689''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0249183 HSALNT0249183]
−
|[[LINC00689]]
+
|[[PCAT18]]
−
|N/A
+
|LINC01092
−
|long intergenic non-protein coding RNA 689
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00692''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290029 HSALNT0290029]
−
|[[LINC00692]]
+
|[[LOC728606]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 692
+
|NA
−
|_
+
|pathogenic process
 +
|prostate cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC00704''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288956 HSALNT0288956]
−
|[[LINC00704]]
+
|[[ENST00000547963.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 704
+
|NA
−
|breast cancer
+
|pathogenic process
 +
|esophageal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00705''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289802 HSALNT0289802]
−
|[[LINC00705]]
+
|[[ENST00000435885]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 705
+
|NA
−
|breast cancer
+
|pathogenic process
 +
|oesophageal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00839''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205898 HSALNT0205898]
−
|[[LINC00839]]
+
|[[LINC01232]]
−
|N/A
+
|FLJ41590,TCONS_00021520
−
|long intergenic non-protein coding RNA 839
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00852''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0257311 HSALNT0257311]
−
|[[LINC00852]]
+
|[[LINC01233]]
−
|"NAG73, GHRL-AS2"
+
|XLOC_013014
−
|long intergenic non-protein coding RNA 852
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00854''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183247 HSALNT0183247]
−
|[[LINC00854]]
+
|[[ENST00000526269.2]]
−
|N/A
+
|FLI1-AS1
−
|long intergenic non-protein coding RNA 854
+
|NA
−
|_
+
|pathogenic process
 +
|vascular SMC phenotype
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00857''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289296 HSALNT0289296]
−
|[[LINC00857]]
+
|[[LINC00467]]
−
|N/A
+
|C1orf97,MGC14801
−
|long intergenic non-protein coding RNA 857
+
|NA
−
|lung cancer
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC00868''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0143586 HSALNT0143586]
−
|[[LINC00868]]
+
|[[CASC21]]
−
|N/A
+
|LINC01244,CARLo-2
−
|long intergenic non-protein coding RNA 868
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00869''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288906 HSALNT0288906]
−
|[[LINC00869]]
+
|[[CASC19]]
−
|KIAA0493
+
|LINC01245,CARLo-6
−
|long intergenic non-protein coding RNA 869
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC00880''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289754 HSALNT0289754]
−
|[[LINC00880]]
+
|[[ENSG00000135253.9]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 880
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00882''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289755 HSALNT0289755]
−
|[[LINC00882]]
+
|[[ENSG00000147753.5]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 882
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00887''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289756 HSALNT0289756]
−
|[[LINC00887]]
+
|[[ENSG00000196096]]
−
|linc-ATP13A4-8
+
|AC079610.1
−
|long intergenic non-protein coding RNA 887
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00893''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289757 HSALNT0289757]
−
|[[LINC00893]]
+
|[[ENSG00000197251.3]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 893
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00901''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289758 HSALNT0289758]
−
|[[LINC00901]]
+
|[[ENSG00000203325]]
−
|"TCONSN/A00005428, BC040587"
+
|AL445248.1
−
|long intergenic non-protein coding RNA 901
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00917''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289759 HSALNT0289759]
−
|[[LINC00917]]
+
|[[ENSG00000206129]]
−
|N/A
+
|AC006305.1
−
|long intergenic non-protein coding RNA 917
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00936''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289760 HSALNT0289760]
−
|[[LINC00936]]
+
|[[ENSG00000215231.3]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 936
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00942''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289761 HSALNT0289761]
−
|[[LINC00942]]
+
|[[ENSG00000215374.4]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 942
+
|NA
−
|autism spectrum disorder
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00950''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289762 HSALNT0289762]
−
|[[LINC00950]]
+
|[[ENSG00000215808.2]]
−
|FP588
+
|NA
−
|long intergenic non-protein coding RNA 950
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00951''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289763 HSALNT0289763]
−
|[[LINC00951]]
+
|[[ENSG00000226496.1]]
−
|"lincRNA-uc003opf.1, FLJ41649"
+
|NA
−
|long intergenic non-protein coding RNA 951
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00961''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289764 HSALNT0289764]
−
|[[LINC00961]]
+
|[[ENSG00000229563.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 961
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00963''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289765 HSALNT0289765]
−
|[[LINC00963]]
+
|[[ENSG00000230133.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 963
+
|NA
−
|prostate cancer
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00964''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289766 HSALNT0289766]
−
|[[LINC00964]]
+
|[[ENSG00000230544.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 964
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00970''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289767 HSALNT0289767]
−
|[[LINC00970]]
+
|[[ENSG00000231133.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 970
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00974''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289768 HSALNT0289768]
−
|[[LINC00974]]
+
|[[ENSG00000231185]]
−
|N/A
+
|AC010317.1
−
|long intergenic non-protein coding RNA 974
+
|NA
−
|hepatocellular carcinoma
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00977''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289769 HSALNT0289769]
−
|[[LINC00977]]
+
|[[ENSG00000232021.2]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 977
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00982''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289770 HSALNT0289770]
−
|[[LINC00982]]
+
|[[ENSG00000232046.1]]
−
|FLJ42875
+
|NA
−
|long intergenic non-protein coding RNA 982
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00993''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289771 HSALNT0289771]
−
|[[LINC00993]]
+
|[[ENSG00000232956.3]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 993
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00994''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289772 HSALNT0289772]
−
|[[LINC00994]]
+
|[[ENSG00000233154.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 994
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC00996''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289773 HSALNT0289773]
−
|[[LINC00996]]
+
|[[ENSG00000233251]]
−
|N/A
+
|AC007743.1
−
|long intergenic non-protein coding RNA 996
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01016''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289774 HSALNT0289774]
−
|[[LINC01016]]
+
|[[ENSG00000235285.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1016
+
|NA
−
|Breast Cancer
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01018''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289775 HSALNT0289775]
−
|[[LINC01018]]
+
|[[ENSG00000237036.3]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1018
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01019''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289776 HSALNT0289776]
−
|[[LINC01019]]
+
|[[ENSG00000237548.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1019
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01020''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289777 HSALNT0289777]
−
|[[LINC01020]]
+
|[[ENSG00000240453.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1020
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01021''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289778 HSALNT0289778]
−
|[[LINC01021]]
+
|[[ENSG00000241269.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1021
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01024''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289779 HSALNT0289779]
−
|[[LINC01024]]
+
|[[ENSG00000245910.3]]
−
|MA-linc1
+
|NA
−
|long intergenic non-protein coding RNA 1024
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01029''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289780 HSALNT0289780]
−
|[[LINC01029]]
+
|[[ENSG00000248176]]
−
|N/A
+
|AC109349.1
−
|long intergenic non-protein coding RNA 1029
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01080''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289781 HSALNT0289781]
−
|[[LINC01080]]
+
|[[ENSG00000249364]]
−
|TCONSN/A00021856
+
|AC112206.2
−
|long intergenic non-protein coding RNA 1080
+
|NA
−
|Alzheimer's disease ;amnestic mild cognitive impairment
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01081''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289782 HSALNT0289782]
−
|[[LINC01081]]
+
|[[ENSG00000249772]]
−
|TCONSN/A00024764
+
|AC026427.1
−
|long intergenic non-protein coding RNA 1081
+
|NA
−
|alveolar capillary dysplasia ;misalignment of pulmonary veins
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01082''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289783 HSALNT0289783]
−
|[[LINC01082]]
+
|[[ENSG00000250195]]
−
|TCONSN/A00024492
+
|AC109927.1
−
|long intergenic non-protein coding RNA 1082
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01089''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289784 HSALNT0289784]
−
|[[LINC01089]]
+
|[[ENSG00000250608]]
−
|N/A
+
|AC010210.1
−
|long intergenic non-protein coding RNA 1089
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01090''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289785 HSALNT0289785]
−
|[[LINC01090]]
+
|[[ENSG00000254154]]
−
|N/A
+
|AL359075.2
−
|long intergenic non-protein coding RNA 1090
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01091''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289786 HSALNT0289786]
−
|[[LINC01091]]
+
|[[ENSG00000255471]]
−
|N/A
+
|AP001528.2
−
|long intergenic non-protein coding RNA 1091
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01096''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289787 HSALNT0289787]
−
|[[LINC01096]]
+
|[[ENSG00000256218]]
−
|N/A
+
|AC007848.2
−
|long intergenic non-protein coding RNA 1096
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01105''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289788 HSALNT0289788]
−
|[[LINC01105]]
+
|[[ENSG00000259150.1]]
−
|"FLJ30594, LOC150622"
+
|NA
−
|long intergenic non-protein coding RNA 1105
+
|NA
−
|predicted disease-related genes
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01108''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289789 HSALNT0289789]
−
|[[LINC01108]]
+
|[[ENSG00000259334.1]]
−
|LncRNA-ES1
+
|NA
−
|long intergenic non-protein coding RNA 1108
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01122''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289790 HSALNT0289790]
−
|[[LINC01122]]
+
|[[ENSG00000259484.1]]
−
|FLJ30838
+
|NA
−
|long intergenic non-protein coding RNA 1122
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01133''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289791 HSALNT0289791]
−
|[[LINC01133]]
+
|[[ENSG00000259758.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1133
+
|NA
−
|lung squamous cell cancer
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01139''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289793 HSALNT0289793]
−
|[[LINC01139]]
+
|[[ENSG00000263753.1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1139
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01140''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289794 HSALNT0289794]
−
|[[LINC01140]]
+
|[[ENSG00000264772]]
−
|FLJ41676
+
|AC016876.2
−
|long intergenic non-protein coding RNA 1140
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01150''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289795 HSALNT0289795]
−
|[[LINC01150]]
+
|[[ENSG00000266952.1]]
−
|"2G7, TCONSN/A00019134"
+
|NA
−
|long intergenic non-protein coding RNA 1150
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01152''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289828 HSALNT0289828]
−
|[[LINC01152]]
+
|[[FAM66B]]
−
|"TCONSN/A00025128, CMPD"
+
|FAM66E
−
|long intergenic non-protein coding RNA 1152
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01154''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289895 HSALNT0289895]
−
|[[LINC01154]]
+
|[[LINC00336]]
−
|N/A
+
|C6orf227,NCRNA00336
−
|long intergenic non-protein coding RNA 1154
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01157''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289899 HSALNT0289899]
−
|[[LINC01157]]
+
|[[LINC00929]]
−
|"TCONSN/A00010378, linc-Enc1"
+
|NA
−
|long intergenic non-protein coding RNA 1157
+
|NA
−
|brain development
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01158''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289906 HSALNT0289906]
−
|[[LINC01158]]
+
|[[LINC01204]]
−
|linc-Brn1a
+
|NA
−
|long intergenic non-protein coding RNA 1158
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01159''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289912 HSALNT0289912]
−
|[[LINC01159]]
+
|[[LINC01538]]
−
|linc-Brn1b
+
|NA
−
|long intergenic non-protein coding RNA 1159
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01184''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289915 HSALNT0289915]
−
|[[LINC01184]]
+
|[[LINC01721]]
−
|FLJ33630
+
|NA
−
|long intergenic non-protein coding RNA 1184
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01185''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289916 HSALNT0289916]
−
|[[LINC01185]]
+
|[[LINC01762]]
−
|FLJ16341
+
|NA
−
|long intergenic non-protein coding RNA 1185
+
|NA
−
|Psoriasis
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01192''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289917 HSALNT0289917]
−
|[[LINC01192]]
+
|[[LINC01798]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1192
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01193''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290247 HSALNT0290247]
−
|[[LINC01193]]
+
|[[SMIM2-IT1]]
−
|LOC348120
+
|C13orf44-IT1
−
|long intergenic non-protein coding RNA 1193
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01194''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290316 HSALNT0290316]
−
|[[LINC01194]]
+
|[[TTTY7]]
−
|TAG
+
|CLONE795723,LINC00129,NCRNA00129A,TTTY7B,TTY7,TTTY7
−
|long intergenic non-protein coding RNA 1194
+
|NA
−
|_
+
|pathogenic process
 +
|hereditary haemorrhagic telangiectasia
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01202''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290175 HSALNT0290175]
−
|[[LINC01202]]
+
|[[RNA-a]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1202
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|Opitz-Kaveggia syndrome
 +
|NA
 
|-
 
|-
−
|''LINC01207''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289525 HSALNT0289525]
−
|[[LINC01207]]
+
|[[116HG]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1207
+
|transcriptional regulation
−
|Lung adenocarcinoma
+
|pathogenic process
 +
|Prader-Willi syndrome
 +
|Nervous System Diseases
 
|-
 
|-
−
|''LINC01225''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290320 HSALNT0290320]
−
|[[LINC01225]]
+
|[[U1 spliceosomal lncRNA]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1225
+
|NA
−
|hepatocellular carcinoma
+
|pathogenic process
 +
|Parkinson's disease
 +
|Nervous System Diseases
 
|-
 
|-
−
|''LINC01228''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289102 HSALNT0289102]
−
|[[LINC01228]]
+
|[[LINC01262]]
−
|lincRNA-DYNLRB2-2
+
|TCONS_l2_00021807,RP11-462G22.1
−
|long intergenic non-protein coding RNA 1228
+
|ceRNA
−
|_
+
|pathogenic process
 +
|Parkinson's disease
 +
|Nervous System Diseases
 
|-
 
|-
−
|''LINC01230''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289681 HSALNT0289681]
−
|[[LINC01230]]
+
|[[CCAT1-L]]
−
|"linc-DMRT2, lnc-DRMT2, TCONSN/A00015639"
+
|NA
−
|long intergenic non-protein coding RNA 1230
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01232''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290062 HSALNT0290062]
−
|[[LINC01232]]
+
|[[MT-LIPCAR]]
−
|"FLJ41590, TCONSN/A00021520"
+
|uc022bqs.1,LIPCAR
−
|long intergenic non-protein coding RNA 1232
+
|NA
−
|_
+
|pathogenic process
 +
|heart disease
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01233''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289941 HSALNT0289941]
−
|[[LINC01233]]
+
|[[LIPCAR]]
−
|XLOCN/A013014
+
|NA
−
|long intergenic non-protein coding RNA 1233
+
|NA
−
|_
+
|pathogenic process
 +
|heart failure
 +
|Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01234''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0200965 HSALNT0200965]
−
|[[LINC01234]]
+
|[[TUSC8]]
−
|onco-lncRNA-32
+
|LINC01071,XLOC_010588
−
|long intergenic non-protein coding RNA 1234
+
|NA
−
|oesophageal squamous cell carcinoma
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINC01252''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0161787 HSALNT0161787]
−
|[[LINC01252]]
+
|[[LINC01264]]
−
|N/A
+
|RP11-124O11.2
−
|long intergenic non-protein coding RNA 1252
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01262''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289733 HSALNT0289733]
−
|[[LINC01262]]
+
|[[D4Z4]]
−
|"TCONSN/Al2N/A00021807, RP11-462G22.1"
+
|NA
−
|long intergenic non-protein coding RNA 1262
+
|NA
−
|Parkinson's disease
+
|pathogenic process;developmental process
 +
|facioscapulohumeral muscular dystrophy
 +
|Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC01264''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289678 HSALNT0289678]
−
|[[LINC01264]]
+
|[[CARL]]
−
|RP11-124O11.2
+
|NA
−
|long intergenic non-protein coding RNA 1264
+
|ceRNA
−
|_
+
|pathogenic process
 +
|myocardial infarction
 +
|Cardiovascular Diseases
 
|-
 
|-
−
|''LINC01268''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289923 HSALNT0289923]
−
|[[LINC01268]]
+
|[[Linc-CBR1-2]]
−
|LOC285758
+
|NA
−
|long intergenic non-protein coding RNA 1268
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01296''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0243354 HSALNT0243354]
−
|[[LINC01296]]
+
|[[Lnc-HEATR6-1:4]]
−
|FLJ39632
+
|WAP four-disulfide core domain 21,pseudogene
−
|long intergenic non-protein coding RNA 1296
+
|transcriptional regulation
−
|prognostic biomarker
+
|pathogenic process
 +
|DC dysfunction
 +
|NA
 
|-
 
|-
−
|''LINC01312''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290232 HSALNT0290232]
−
|[[LINC01312]]
+
|[[RUNX1]]
−
|MGC34034
+
|NA
−
|long intergenic non-protein coding RNA 1312
+
|NA
−
|_
+
|pathogenic process
 +
|acute myeloid leukemia
 +
|Neoplasms
 
|-
 
|-
−
|''LINC01317''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290234 HSALNT0290234]
−
|[[LINC01317]]
+
|[[RUNXOR]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1317
+
|NA
−
|_
+
|pathogenic process
 +
|hematopoietic malignancies
 +
|Neoplasms;Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''LINC01370''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289979 HSALNT0289979]
−
|[[LINC01370]]
+
|[[LncRNA-CIR]]
−
|HI-LNC25
+
|NA
−
|long intergenic non-protein coding RNA 1370
+
|NA
−
|_
+
|pathogenic process
 +
|osteoarthritis
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''LINC01374''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290368 HSALNT0290368]
−
|[[LINC01374]]
+
|[[VIM2P]]
−
|TCONSN/A00018278
+
|NA
−
|long intergenic non-protein coding RNA 1374
+
|NA
−
|hepatocellular carcinoma
+
|pathogenic process
 +
|osteoarthritis
 +
|Musculoskeletal Diseases
 
|-
 
|-
−
|''LINC01405''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289879 HSALNT0289879]
−
|[[LINC01405]]
+
|[[KRAS1P]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1405
+
|NA
−
|_
+
|pathogenic process
 +
|cancer
 +
|Neoplasms
 
|-
 
|-
−
|''LINC01411''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290054 HSALNT0290054]
−
|[[LINC01411]]
+
|[[MINA]]
−
|RP11-267A15.1
+
|NA
−
|long intergenic non-protein coding RNA 1411
+
|NA
−
|prostate cancer
+
|pathogenic process
 +
|esophageal squamous cell cancer;gastric cancer;lung cancer;hepatocelluar cancer
 +
|Respiratory Tract Diseases;Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01420''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289270 HSALNT0289270]
−
|[[LINC01420]]
+
|[[TMEM92-AS1]]
−
|N/A
+
|RP11-893F2.9,lncRNA-508851,TCONS_00025237
−
|long intergenic non-protein coding RNA 1420
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01433''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0288900 HSALNT0288900]
−
|[[LINC01433]]
+
|[[ENST00000604200.1]]
−
|LOC728228
+
|LINC00468
−
|long intergenic non-protein coding RNA 1433
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01435''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289593 HSALNT0289593]
−
|[[LINC01435]]
+
|[[AK123657]]
−
|"RP11-215N21.1, TCONSN/A00018040"
+
|NA
−
|long intergenic non-protein coding RNA 1435
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01436''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289659 HSALNT0289659]
−
|[[LINC01436]]
+
|[[BX648207]]
−
|AP000688.8
+
|NA
−
|long intergenic non-protein coding RNA 1436
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01468''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289660 HSALNT0289660]
−
|[[LINC01468]]
+
|[[BX649059]]
−
|lnc-MBL2-4
+
|NA
−
|long intergenic non-protein coding RNA 1468
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01478''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289846 HSALNT0289846]
−
|[[LINC01478]]
+
|[[GAS2L3]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1478
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01501''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289633 HSALNT0289633]
−
|[[LINC01501]]
+
|[[BC011663]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1501
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01503''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289867 HSALNT0289867]
−
|[[LINC01503]]
+
|[[HIV1230]]
−
|lnc-PPP2R4-5
+
|NA
−
|long intergenic non-protein coding RNA 1503
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01507''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290045 HSALNT0290045]
−
|[[LINC01507]]
+
|[[M14574]]
−
|XLOCN/A000303
+
|NA
−
|long intergenic non-protein coding RNA 1507
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01511''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290245 HSALNT0290245]
−
|[[LINC01511]]
+
|[[SLCO5A1]]
−
|RP11-325I22.2
+
|NA
−
|long intergenic non-protein coding RNA 1511
+
|NA
−
|lung adenocarcinoma
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01512''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290326 HSALNT0290326]
−
|[[LINC01512]]
+
|[[Uc.341]]
−
|"LOC100132354, TCONSN/A00011120, HI-LNC77"
+
|NA
−
|long intergenic non-protein coding RNA 1512
+
|NA
−
|type 2 diabetes
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01513''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290344 HSALNT0290344]
−
|[[LINC01513]]
+
|[[Uc003iqu]]
−
|"RP11-1C1.7, TCONSN/A00009352"
+
|NA
−
|long intergenic non-protein coding RNA 1513
+
|NA
−
|lung adenocarcinoma
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01525''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290346 HSALNT0290346]
−
|[[LINC01525]]
+
|[[Uc003tfx]]
−
|lnc-MAN1A2-1
+
|NA
−
|long intergenic non-protein coding RNA 1525
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01526''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289950 HSALNT0289950]
−
|[[LINC01526]]
+
|[[Lnc-AL355149.1-1]]
−
|Lnc-FAM46A-1
+
|NA
−
|long intergenic non-protein coding RNA 1526
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC01527''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290001 HSALNT0290001]
−
|[[LINC01527]]
+
|[[Lnc-ZNF674-1]]
−
|lnc-SPRR2D-1
+
|NA
−
|long intergenic non-protein coding RNA 1527
+
|NA
−
|_
+
|pathogenic process
 +
|nasopharyngeal cancer
 +
|Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases
 
|-
 
|-
−
|''LINC01537''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0286909 HSALNT0286909]
−
|[[LINC01537]]
+
|[[LINC00632]]
−
|RP11-169D4.1-001
+
|NA
−
|long intergenic non-protein coding RNA 1537
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01547''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289105 HSALNT0289105]
−
|[[LINC01547]]
+
|[[LINC01317]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1547
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC01553''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0234804 HSALNT0234804]
−
|[[LINC01553]]
+
|[[LINC01081]]
−
|AC023904.2
+
|TCONS_00024764
−
|long intergenic non-protein coding RNA 1553
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|alveolar capillary dysplasia
 +
|Respiratory Tract Diseases
 
|-
 
|-
−
|''LINC01558''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289840 HSALNT0289840]
−
|[[LINC01558]]
+
|[[FOSB]]
−
|"HGC6.2, dJ431P23.4"
+
|NA
−
|long intergenic non-protein coding RNA 1558
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01559''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289587 HSALNT0289587]
−
|[[LINC01559]]
+
|[[AK093543]]
−
|FLJ33810
+
|NA
−
|long intergenic non-protein coding RNA 1559
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01560''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289732 HSALNT0289732]
−
|[[LINC01560]]
+
|[[D16366]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1560
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01562''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289814 HSALNT0289814]
−
|[[LINC01562]]
+
|[[ENST00000501583]]
−
|RP11-296A18.3
+
|NA
−
|long intergenic non-protein coding RNA 1562
+
|NA
−
|intervertebral disc degeneration
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LINC01564''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289907 HSALNT0289907]
−
|[[LINC01564]]
+
|[[LINC01374]]
−
|TCONSN/A00011314
+
|TCONS_00018278
−
|long intergenic non-protein coding RNA 1564
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINC01565''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0231106 HSALNT0231106]
−
|[[LINC01565]]
+
|[[CASC22]]
−
|GR6
+
|LINC01373,TCONS_00024290,LincRNA-ENST00000515084
−
|long intergenic non-protein coding RNA 1565
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01574''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0058246 HSALNT0058246]
−
|[[LINC01574]]
+
|[[LINC00882]]
−
|"HI-LNC12, TCONSN/A00009551"
+
|NA
−
|long intergenic non-protein coding RNA 1574
+
|ceRNA
−
|type 2 diabetes
+
|pathogenic process
 +
|airway diseases
 +
|Respiratory Tract Diseases
 
|-
 
|-
−
|''LINC01587''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0018288 HSALNT0018288]
−
|[[LINC01587]]
+
|[[KIAA1614-AS1]]
−
|aC1
+
|RP11-46A10.4
−
|long intergenic non-protein coding RNA 1587
+
|ceRNA
−
|_
+
|pathogenic process
 +
|airway smooth muscle (ASM) disease
 +
|Respiratory Tract Diseases
 
|-
 
|-
−
|''LINC01589''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0142310 HSALNT0142310]
−
|[[LINC01589]]
+
|[[LINC00536]]
−
|"CTA-941F9.9, TCONSN/A00029353"
+
|NA
−
|long intergenic non-protein coding RNA 1589
+
|NA
−
|_
+
|pathogenic process
 +
|trichorhinophalangeal syndrome
 +
|NA
 
|-
 
|-
−
|''LINC01591''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0034200 HSALNT0034200]
−
|[[LINC01591]]
+
|[[LBX2-AS1]]
−
|N/A
+
|NA
−
|long intergenic non-protein coding RNA 1591
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01602''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0149799 HSALNT0149799]
−
|[[LINC01602]]
+
|[[ENST00000414223]]
−
|T1560
+
|NA
−
|long intergenic non-protein coding RNA 1602
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01611''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290012 HSALNT0290012]
−
|[[LINC01611]]
+
|[[LOC105374631]]
−
|"RP1-90L14.1, TCONSN/Al2N/A00025430"
+
|NA
−
|long intergenic non-protein coding RNA 1611
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01612''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290305 HSALNT0290305]
−
|[[LINC01612]]
+
|[[TMEM179]]
−
|"RP11-789C1.1, TCONSN/A00008319"
+
|NA
−
|long intergenic non-protein coding RNA 1612
+
|NA
−
|gastric cancer
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01613''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290315 HSALNT0290315]
−
|[[LINC01613]]
+
|[[TSPAN8]]
−
|n341773
+
|NA
−
|long intergenic non-protein coding RNA 1613
+
|NA
−
|idiopathic pulmonary fibrosis
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01614''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290334 HSALNT0290334]
−
|[[LINC01614]]
+
|[[Uc001aka.2]]
−
|"LCAL4, TCONSN/A00003105"
+
|NA
−
|long intergenic non-protein coding RNA 1614
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01616''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290339 HSALNT0290339]
−
|[[LINC01616]]
+
|[[Uc001vjj.1]]
−
|n341006
+
|NA
−
|long intergenic non-protein coding RNA 1616
+
|NA
−
|Alzheimer's disease
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01617''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290343 HSALNT0290343]
−
|[[LINC01617]]
+
|[[Uc003erl.1]]
−
|XLOCN/A006844
+
|NA
−
|long intergenic non-protein coding RNA 1617
+
|NA
−
|_
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01618''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290354 HSALNT0290354]
−
|[[LINC01618]]
+
|[[Uc009wkz.1]]
−
|LOC152578
+
|NA
−
|long intergenic non-protein coding RNA 1618
+
|NA
−
|colorectal cancer
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''LINC01622''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027893 HSALNT0027893]
−
|[[LINC01622]]
+
|[[ENST00000433810.1]]
−
|TCONSN/A00011202
+
|MYCNUN,lncUSMycN
−
|long intergenic non-protein coding RNA 1622
+
|NA
−
|_
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''LINC01627''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0273205 HSALNT0273205]
−
|[[LINC01627]]
+
|[[LINC01436]]
−
|RP11-397D12.4
+
|AP000688.8
−
|long intergenic non-protein coding RNA 1627
+
|NA
−
|NSCLC
+
|pathogenic process
 +
|Down syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases
 
|-
 
|-
−
|''LINC01628''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266116 HSALNT0266116]
−
|[[LINC01628]]
+
|[[MIR663AHG]]
−
|AC007403.1
+
|RP3-410C9.1
−
|long intergenic non-protein coding RNA 1628
+
|NA
−
|_
+
|pathogenic process
 +
|turner syndrome
 +
|Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases
 
|-
 
|-
−
|''LINC01629''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289108 HSALNT0289108]
−
|[[LINC01629]]
+
|[[LINC01435]]
−
|linc-KIAA1737-2
+
|RP11-215N21.1,TCONS_00018040
−
|long intergenic non-protein coding RNA 1629
+
|NA
−
|_
+
|pathogenic process
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LINCMD1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289674 HSALNT0289674]
−
|[[LINCMD1]]
+
|[[CADM3-AS1]]
−
|N/A
+
|NA
−
|"long intergenic non-protein coding RNA, muscle differentiation 1"
+
|NA
−
|Duchenne muscular dystrophy
+
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LINGO1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289882 HSALNT0289882]
−
|[[LINGO1-AS1]]
+
|[[KRT19P3]]
−
|N/A
+
|NA
−
|LINGO1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LMCD1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290310 HSALNT0290310]
−
|[[LMCD1-AS1]]
+
|[[TNXA]]
−
|N/A
+
|NA
−
|LMCD1 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''LOH12CR2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0008750 HSALNT0008750]
−
|[[LOH12CR2]]
+
|[[ZRANB2-AS2]]
−
|LOH2CR12
+
|NA
−
|"loss of heterozygosity, 12, chromosomal region 2 (non-protein coding)"
+
|NA
−
|tumour suppressor
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LOXL1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289745 HSALNT0289745]
−
|[[LOXL1-AS1]]
+
|[[DMTF1]]
−
|N/A
+
|NA
−
|LOXL1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LPP-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290059 HSALNT0290059]
−
|[[LPP-AS2]]
+
|[[MRUL]]
−
|N/A
+
|NA
−
|LPP antisense RNA 2
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LRP1-AS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0185163 HSALNT0185163]
−
|[[LRP1-AS]]
+
|[[FAM66C]]
−
|N/A
+
|NA
−
|LRP1 antisense RNA
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LRRC75A-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289476 HSALNT0289476]
−
|[[LRRC75A-AS1]]
+
|[[ENST00000357401.3]]
−
|MGC40157
+
|NA
−
|LRRC75A antisense RNA 1
+
|NA
−
|_
+
|NA
 +
|NA
 +
|NA
 
|-
 
|-
−
|''LUADT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289535 HSALNT0289535]
−
|[[LUADT1]]
+
|[[AA174084]]
−
|N/A
+
|NA
−
|lung adenocarcinoma associated transcript 1
+
|NA
−
|lung adenocarcinoma
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''LUNAR1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0266298 HSALNT0266298]
−
|[[LUNAR1]]
+
|[[ABALON]]
−
|N/A
+
|INXS
−
|leukemia-associated non-coding IGF1R activator RNA 1
+
|splicing regulation
−
|leukemia
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''MAFA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290370 HSALNT0290370]
−
|[[MAFA-AS1]]
+
|[[VTRNA2-1]]
−
|"RP11-909N17.3, TCONSN/A00014882"
+
|CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886,svtRNA2-1a
−
|MAFA antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MAFG-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289619 HSALNT0289619]
−
|[[MAFG-AS1]]
+
|[[ASK00420]]
−
|N/A
+
|NA
−
|MAFG antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MAFTRR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289749 HSALNT0289749]
−
|[[MAFTRR]]
+
|[[EBIC]]
−
|linc-MAF-4
+
|NA
−
|MAF transcriptional regulator RNA
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MAGEA8-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290299 HSALNT0290299]
−
|[[MAGEA8-AS1]]
+
|[[TI09485]]
−
|RP5-869M20.2
+
|NA
−
|MAGEA8 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MAPKAPK5-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290300 HSALNT0290300]
−
|[[MAPKAPK5-AS1]]
+
|[[TI10124]]
−
|FLJ39616
+
|NA
−
|MAPKAPK5 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MCM3AP-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290301 HSALNT0290301]
−
|[[MCM3AP-AS1]]
+
|[[TI13831]]
−
|"FLJ10508, NCRNA00031"
+
|NA
−
|MCM3AP antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MDC1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290302 HSALNT0290302]
−
|[[MDC1-AS1]]
+
|[[TI18318]]
−
|MDC1-AS
+
|NA
−
|MDC1 antisense RNA 1
+
|NA
−
| bladder cancer
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MEF2C-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290303 HSALNT0290303]
−
|[[MEF2C-AS1]]
+
|[[TI21327]]
−
|N/A
+
|NA
−
|MEF2C antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MEG9''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290304 HSALNT0290304]
−
|[[ENST00000553584.1]]
+
|[[TI22687]]
−
|LINC00584
+
|NA
−
|maternally expressed 9 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MESTIT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290307 HSALNT0290307]
−
|[[MESTIT1]]
+
|[[TMPOP2]]
−
|"NCRNA00040, MEST-AS1"
+
|NA
−
|"MEST intronic transcript 1, antisense RNA"
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|cervical cancer
 +
|Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''MGAT3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289570 HSALNT0289570]
−
|[[MGAT3-AS1]]
+
|[[AK021444]]
−
|TapSAKI
+
|NA
−
|MGAT3 antisense RNA 1
+
|NA
−
|acute kidney injury
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MHRT''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289601 HSALNT0289601]
−
|[[MHRT]]
+
|[[AK307796]]
−
|Myheart
+
|NA
−
|myosin heavy chain-associated RNA transcript
+
|NA
−
|heart pathological hypertrophy
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIF-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289801 HSALNT0289801]
−
|[[MIF-AS1]]
+
|[[ENST00000425785]]
−
|LOC284889
+
|SEC63P1
−
|MIF antisense RNA 1
+
|NA
−
|malaria susceptibility
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIMT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289871 HSALNT0289871]
−
|[[MIMT1]]
+
|[[HOXB-AS3]]
−
|"MIM1, NCRNA00067, LINC00067"
+
|NA
−
|MER1 repeat containing imprinted transcript 1 (non-protein coding)
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MINCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290367 HSALNT0290367]
−
|[[ENST00000517411.1]]
+
|[[URHC]]
−
|TCONSN/A00015189
+
|NA
−
|MYC-induced long noncoding RNA
+
|NA
−
|Burkitt lymphoma
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR137HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289085 HSALNT0289085]
−
|[[MIR137HG]]
+
|[[LINC01080]]
−
|N/A
+
|TCONS_00021856
−
|MIR137 host gene
+
|NA
−
|schizophrenia
+
|pathogenic process
 +
|Alzheimer's disease
 +
|Mental Disorders;Nervous System Diseases
 
|-
 
|-
−
|''MIR17HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289751 HSALNT0289751]
−
|[[MIR17HG]]
+
|[[EFNA3]]
−
|"FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048"
+
|NA
−
|miR-17-92a-1 cluster host gene
+
|NA
−
|lymphoma, syndromic developmental defect
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''MIR181A2HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289798 HSALNT0289798]
−
|[[MIR181A2HG]]
+
|[[ENST00000395084]]
−
|N/A
+
|NA
−
|MIR181A2 host gene
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR210HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289829 HSALNT0289829]
−
|[[MIR210HG]]
+
|[[FAM83A-AS1]]
−
|N/A
+
|NA
−
|MIR210 host gene
+
|NA
−
|inflammatory renal epithelial injury
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR34AHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290164 HSALNT0290164]
−
|[[MIR34AHG]]
+
|[[RAD1]]
−
|N/A
+
|NA
−
|MIR34A host gene
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocelluar cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR4435-2HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289585 HSALNT0289585]
−
|[[MIR4435-2HG]]
+
|[[AK056988]]
−
|"LINC00978, AGD2, AK001796"
+
|NA
−
|MIR4435-2 host gene
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR600HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289638 HSALNT0289638]
−
|[[MIR600HG]]
+
|[[BC017743]]
−
|"GL012, FLJ22161"
+
|NA
−
|MIR600 host gene
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR663AHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290156 HSALNT0290156]
−
|[[MIR663AHG]]
+
|[[PRR26]]
−
|RP3-410C9.1
+
|C10orf108
−
|MIR663A host gene
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIR7-3HG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290349 HSALNT0290349]
−
|[[MIR7-3HG]]
+
|[[Uc003yqb.1]]
−
|"PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2"
+
|NA
−
|MIR7-3 host gene
+
|NA
−
|_
+
|pathogenic process
 +
|hepatocellular cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''MIRLET7BHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289675 HSALNT0289675]
−
|[[MIRLET7BHG]]
+
|[[CAI2]]
−
|linc-Ppara
+
|NA
−
|MIRLET7B host gene
+
|NA
−
|asbestos exposure-related lung cancer
+
|pathogenic process
 +
|neuroblastoma
 +
|Neoplasms
 
|-
 
|-
−
|''MIRLET7DHG''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290313 HSALNT0290313]
−
|[[MIRLET7DHG]]
+
|[[TSLC1-AS1]]
−
|N/A
+
|NA
−
|MIRLET7D host gene
+
|NA
−
|_
+
|pathogenic process
 +
|glioma
 +
|Neoplasms
 
|-
 
|-
−
|''MKRN3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0013359 HSALNT0013359]
−
|[[MKRN3-AS1]]
+
|[[LINC01525]]
−
|"FNZ127, NCRNA00009, ZNF127-AS"
+
|lnc-MAN1A2-1
−
|MKRN3 antisense RNA 1
+
|NA
−
|Prader-Willi syndrome ;Angelman syndromes
+
|pathogenic process
 +
|squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''MLK7-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0109106 HSALNT0109106]
−
|[[MLK7-AS1]]
+
|[[LINC01526]]
−
|N/A
+
|Lnc-FAM46A-1
−
|MLK7 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''MLLT4-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0162774 HSALNT0162774]
−
|[[MLLT4-AS1]]
+
|[[LINC01468]]
−
|"HGC6.4, dJ431P23.3"
+
|lnc-MBL2-4
−
|MLLT4 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''MORF4L2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289110 HSALNT0289110]
−
|[[MORF4L2-AS1]]
+
|[[LINC01503]]
−
|N/A
+
|lnc-PPP2R4-5
−
|MORF4L2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|tongue squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289968 HSALNT0289968]
 +
|[[Lnc-MBL2-4:3]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|tongue squamous cell cancer
 +
|Neoplasms
 +
|-
 +
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289993 HSALNT0289993]
 +
|[[Lnc-STXBP5-1]]
 +
|NA
 +
|NA
 +
|pathogenic process
 +
|tongue squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''MT-LIPCAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289563 HSALNT0289563]
−
|[[MT-LIPCAR]]
+
|[[AF118081]]
−
|"uc022bqs.1, LIPCAR"
+
|NA
−
|mitochondrially encoded long non-coding cardiac associated RNA
+
|NA
−
|heart failure
+
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''MYCNOS''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289597 HSALNT0289597]
−
|[[MYCNOS]]
+
|[[AK124939]]
−
|"NCYM, N-CYM, MYCN-AS1"
+
|NA
−
|MYCN opposite strand
+
|NA
−
|neuroblastoma
+
|pathogenic process
 +
|pulmonary adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''N4BP2L2-IT2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290153 HSALNT0290153]
−
|[[N4BP2L2-IT2]]
+
|[[PRAS]]
−
|CG030
+
|NA
−
|N4BPL2 intronic transcript 2
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''NALT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290249 HSALNT0290249]
−
|[[NALT1]]
+
|[[SNAR-A1]]
−
|TCONSN/Al2N/A00029132
+
|NA
−
|NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1
+
|NA
−
|_
+
|pathogenic process
 +
|colorectal cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''NBAT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289929 HSALNT0289929]
−
|[[NBAT1]]
+
|[[LincRNA-BC2]]
−
|NBAT-1
+
|NA
−
|neuroblastoma associated transcript 1
+
|NA
−
|Fighting Neuroblastomas ;breast cancer
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''NBR2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289930 HSALNT0289930]
−
|[[NBR2]]
+
|[[LincRNA-BC4]]
−
|NCRNA00192
+
|NA
−
|neighbor of BRCA1 gene 2 (non-protein coding)
+
|NA
 +
|pathogenic process
 
|breast cancer
 
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''NCBP2-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289931 HSALNT0289931]
−
|[[NCBP2-AS2]]
+
|[[LincRNA-BC5]]
−
|N/A
+
|NA
−
|NCBP2 antisense RNA 2 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''NCOA7-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289932 HSALNT0289932]
−
|[[NCOA7-AS1]]
+
|[[LincRNA-BC8]]
−
|N/A
+
|NA
−
|NCOA7 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|breast cancer
 +
|Skin and Connective Tissue Diseases;Neoplasms
 
|-
 
|-
−
|''NCRUPAR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0083190 HSALNT0083190]
−
|[[NCRUPAR]]
+
|[[LINC01511]]
−
|"ncR-uPAR, ncRuPAR, NCRNA00193"
+
|RP11-325I22.2
−
|"non-protein coding RNA, upstream of F2R/PAR1"
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NFIA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290026 HSALNT0290026]
−
|[[NFIA-AS1]]
+
|[[LOC440905]]
−
|RP5-833A20.1
+
|NA
−
|NFIA antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NIPBL-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289552 HSALNT0289552]
−
|[[NIPBL-AS1]]
+
|[[AC079776.2]]
−
|NIPBL-AS
+
|NA
−
|NIPBL antisense RNA 1 (head to head)
+
|NA
−
| autism spectrum disorders
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NKILA''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289720 HSALNT0289720]
−
|[[NKILA]]
+
|[[CTA-363E6.2]]
−
|N/A
+
|NA
−
|NF-kappaB interacting long non-coding RNA
+
|NA
−
| breast cancer
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NKX2-2-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289901 HSALNT0289901]
−
|[[NKX2-2-AS1]]
+
|[[LINC00987]]
−
|NKX2-2AS
+
|NA
−
|NKX2-2 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NOP14-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290185 HSALNT0290185]
−
|[[NOP14-AS1]]
+
|[[RP11-1C1.7]]
−
|RES4-24
+
|NA
−
|NOP14 antisense RNA 1
+
|NA
−
|Huntington disease
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NORAD''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290197 HSALNT0290197]
−
|[[NORAD]]
+
|[[RP11-445K13.2]]
−
|N/A
+
|NA
−
|non-coding RNA activated by DNA damage
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NPHP3-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290199 HSALNT0290199]
−
|[[NPHP3-AS1]]
+
|[[RP11-473M20.11]]
−
|N/A
+
|NA
−
|NPHP3 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NPPA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290213 HSALNT0290213]
−
|[[NPPA-AS1]]
+
|[[RP11-893F2.6]]
−
|N/A
+
|NA
−
|NPPA antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NPSR1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290217 HSALNT0290217]
−
|[[NPSR1-AS1]]
+
|[[RP13-514E23.1]]
−
|"AAA1, IMAGE:4827585"
+
|NA
−
|NPSR1 antisense RNA 1
+
|NA
−
|cardiovascular disease
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NPTN-IT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290218 HSALNT0290218]
−
|[[NPTN-IT1]]
+
|[[RP1-90D4.3]]
−
|lncRNA-LET
+
|NA
−
|NPTN intronic transcript 1
+
|NA
−
|colorectal cancer; hepatocelluar carcinoma;squamous-cell lung carcinomas
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NR2F1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290220 HSALNT0290220]
−
|[[NR2F1-AS1]]
+
|[[RP4-575N6.5]]
−
|FLJ42709
+
|NA
−
|NR2F1 antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''NRAV''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290226 HSALNT0290226]
−
|[[NRAV]]
+
|[[RP5-826L7.1]]
−
|N/A
+
|NA
−
|negative regulator of antiviral response (non-protein coding)
+
|NA
−
|influenza A virus (IAV) infection
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''OLMALINC''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290378 HSALNT0290378]
−
|[[OLMALINC]]
+
|[[XLOC_003286]]
−
|"bA34D15.5, FLJ12974, HI-LNC80"
+
|NA
−
|oligodendrocyte maturation-associated long intergenic non-coding RNA
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''PANCR''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290379 HSALNT0290379]
−
|[[PANCR]]
+
|[[XLOC_003405]]
−
|N/A
+
|NA
−
|PITX2 adjacent non-coding RNA
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''PAPPA-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290389 HSALNT0290389]
−
|[[PAPPA-AS1]]
+
|[[XLOC_012255]]
−
|"PAPPA-AS, DIPAS, TAF4B, TAF2C2, TAFII105, NCRNA00156"
+
|NA
−
|PAPPA antisense RNA 1
+
|NA
−
|_
+
|pathogenic process
 +
|lung adenocarcinoma
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''PAPPA-AS2''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290056 HSALNT0290056]
−
|[[PAPPA-AS2]]
+
|[[MIR21]]
−
|AGU1
+
|NA
−
|PAPPA antisense RNA 2
+
|NA
−
|stem cell differentiation
+
|pathogenic process
 +
|laryngeal squamous cell cancer
 +
|Neoplasms
 
|-
 
|-
−
|''PARTICL''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289621 HSALNT0289621]
−
|[[PARTICL]]
+
|[[ASncmtRNAs]]
−
|PARTICLE
+
|NA
−
|promoter of MAT2A antisense radiation-induced circulating long non-coding RNA
+
|transcriptional regulation
−
|_
+
|pathogenic process
 +
|cancer
 +
|Neoplasms
 
|-
 
|-
−
|''PAXIP1-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289316 HSALNT0289316]
−
|[[PAXIP1-AS1]]
+
|[[LINC01614]]
−
|N/A
+
|LCAL4,TCONS_00003105
−
|PAXIP1 antisense RNA 1 (head to head)
+
|NA
−
|_
+
|pathogenic process
 +
|lung cancer
 +
|Respiratory Tract Diseases;Neoplasms
 
|-
 
|-
−
|''PCAT14''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289982 HSALNT0289982]
−
|[[PCAT14]]
+
|[[LncRNA-FER1L4]]
−
|N/A
+
|NA
−
|prostate cancer associated transcript 14 (non-protein coding)
+
|ceRNA
−
|prostate cancer
+
|pathogenic process
 +
|gastric cancer
 +
|Neoplasms;Digestive System Diseases
 
|-
 
|-
−
|''PCAT18''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290016 HSALNT0290016]
−
|[[PCAT18]]
+
|[[LOC283177]]
−
|LINC01092
+
|NA
−
|prostate cancer associated transcript 18 (non-protein coding)
+
|NA
−
| metastatic prostate cancer
+
|pathogenic process
 +
|diffuse large B-cell lymphoma
 +
|Hemic and Lymphatic Diseases
 
|-
 
|-
−
|''PCAT19''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289003 HSALNT0289003]
−
|[[PCAT19]]
+
|[[HORMAD2-AS1]]
−
|LINC01190
+
|MTMR3-AS1,NONHSAG033653
−
|prostate cancer associated transcript 19 (non-protein coding)
+
|NA
−
|prostate cancer
+
|pathogenic process
 +
|type 1 diabetes;bowel disease
 +
|Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases
 
|-
 
|-
−
|''PCAT29''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290372 HSALNT0290372]
−
|[[PCAT29]]
+
|[[WNT4]]
−
|N/A
+
|NA
−
|prostate cancer associated transcript 29 (non-protein coding)
+
|NA
−
|prostate cancer
+
|pathogenic process
 +
|endometriosis
 +
|Female Urogenital Diseases and Pregnancy Complications
 
|-
 
|-
−
|''PCAT5''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289540 HSALNT0289540]
−
|[[PCAT5]]
+
|[[AB074278]]
−
|TPCAT-10-36067
+
|NA
−
|prostate cancer associated transcript 5 (non-protein coding)
+
|NA
−
|Prostate Cancer
+
|pathogenic process
 +
|bladder cancer
 +
|Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms
 
|-
 
|-
−
|''PCBP2-OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0290166 HSALNT0290166]
−
|[[PCBP2-OT1]]
+
|[[RCCRT1]]
−
|TUC338
+
|NA
−
|PCBP2 overlapping transcript 1
+
|NA
−
|hepatocellular carcinoma
+
|pathogenic process
 +
|renal cell cancer
 +
|Male Urogenital Diseases;Neoplasms
 
|-
 
|-
−
|''PCBP3-OT1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289043 HSALNT0289043]
−
|[[PCBP3-OT1]]
+
|[[LINC00491]]
−
|FLJ44028
+
|BC008363
−
|PCBP3 overlapping transcript 1
+
|NA
−
|DNA damage
+
|pathogenic process
 +
|pancreatic ductal adenocarcinoma
 +
|Neoplasms
 
|-
 
|-
−
|''PCF11-AS1''
+
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289858 HSALNT0289858]
−
|[[PCF11-AS1]]